DRAFT 

REPORT TO THE ADVISORY BOARD 

ON RADIATION AND WORKER HEALTH

National Institute for Occupational Safety and Health 

BLIND DOSE RECONSTRUCTION OF CASE #[REDACTED]

FROM THE Y-12 NATIONAL SECURITY COMPLEX AND 

THE X-10 OAK RIDGE NATIONAL LABORATORY

Contract No. 200-2009-28555

SCA-TR-BDR2014-CN[REDACTED]

Prepared by 

Ron Buchanan 

John Mauro 

Nicole Briggs 

S. Cohen & Associates 

1608 Spring Hill Road, Suite 400 

Vienna, Virginia 22182 

February 2014 

Disclaimer 

This document is made available in accordance with the unanimous desire of the Advisory Board on Radiation and 

Worker Health (ABRWH) to maintain all possible openness in its deliberations. However, the ABRWH and its 

contractor, SC&A, caution the reader that at the time of its release, this report is pre-decisional and has not been 

reviewed by the Board for factual accuracy or applicability within the requirements of 42CFR82. This implies that 

once reviewed by the ABRWH, the Board’s position may differ from the report’s conclusions. Thus, the reader 

should be cautioned that this report is for information only and that premature interpretations regarding its 

conclusions are unwarranted.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

2 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

S. Cohen & Associates:

Technical Support for the Advisory Board on

Radiation & Worker Health Review of

NIOSH Dose Reconstruction Program

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Effective Date: 

Draft – February 24, 2014

Revision No. 0 (Draft)

BLIND DOSE RECONSTRUCTION 

OF CASE #[REDACTED] FROM THE Y-12 

NATIONAL SECURITY COMPLEX AND 

THE X-10 OAK RIDGE NATIONAL 

LABORATORY

Page 2 of 122

Task Manager:

________________________ Date: __________

Douglas Farver, CHP

Supersedes:

N/A

Project Manager:

_______________________ Date: ___________

John Stiver, MS, CHP

Reviewers:

 Kathy Behling

 John Stiver

Record of Revisions

Revision 

Number Effective Date Description of Revision

0 (Draft) 02/24/2014 Initial issued.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

3 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

TABLE OF CONTENTS 

Executive Summary ........................................................................................................................ 5

Relevant Background Information ...................................................................................... 5

Presentation of Results ........................................................................................................ 6

Section I: DR–Method A ............................................................................................................. 10

I.1 Dose Reconstruction Overview ............................................................................ 10

I.1.1 SC&A Blind DR–Method A Approach .................................................... 10

I.2 External Doses ...................................................................................................... 12

I.2.1 Recorded Photon and Electron Doses ....................................................... 12

I.2.2 Missed Photon and Electron Doses........................................................... 14

I.2.3 Neutron Dose ............................................................................................ 15

I.2.4 Occupational Medical Dose ...................................................................... 16

I.2.5 Onsite Ambient Dose ................................................................................ 16

I.3 Internal Doses ....................................................................................................... 17

I.3.1 Y-12 Internal Thorium and Uranium Doses ............................................. 17

I.3.3 Environmental Internal Dose .................................................................... 19

I.4 CATI Report and Radiological Incidents ............................................................. 19

I.5 Summary Conclusions .......................................................................................... 19

I.6 References ............................................................................................................. 19

Appendix A-1: IREP Input – SCC [Redacted] ............................................................................ 21

Appendix A-2: IREP Input – SCC [Redacted] ............................................................................ 27

Appendices A-3 and A-4: IREP Input – BCC [Redacted] ........................................................... 34

Appendix A-5: IREP Input – BCC [Redacted] ............................................................................ 41

Appendix A-6: IREP Input – BCC [Redacted] ............................................................................ 48

Appendix A-7: IREP Input – SCC [Redacted] ............................................................................ 55

Appendix A-8: IREP Input – SCC [Redacted] ............................................................................ 62

Section II: DR–Method B ............................................................................................................ 69

II.1 Dose Reconstruction Overview .............................................................................. 69

II.2 Relevant Background Information ........................................................................ 71

II.3 External Dosimetry Records ................................................................................. 72

II.3.1 Reconstruction of External Doses for Y-12 Employment ........................ 73

II.3.2 Reconstruction of External Dose for X-10 Employment .......................... 79

II.4 Internal Dosimetry Records .................................................................................. 81

II.6 References ............................................................................................................. 85

Appendix II.A-1: IREP Input – [Redacted] SCC [Redacted] ...................................................... 87

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] ...................................................... 92

Appendix II.A-3: IREP Input – [Redacted] BCC [Redacted] ...................................................... 98

Appendix II.A-4: IREP Input – [Redacted] SCC [Redacted] .................................................... 103
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

4 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-5: IREP Input – [Redacted] BCC [Redacted] .................................................... 108

Appendix II.A-6: IREP Input – [Redacted] BCC [Redacted] .................................................... 113

Appendix II.A-7: IREP Input – [Redacted] SCC [Redacted] .................................................... 118

LIST OF TABLES 

Table ES-1. Cancers and Diagnosis Date .......................................................................................5

Table ES-2. Derived Dose Estimates ..............................................................................................7

Table ES-3. Summary of Approach Used by SC&A’s Methods A and B to Calculate 

External and Internal Doses .......................................................................................8

Table I-1. Cancers and Diagnosis Date.........................................................................................10

Table I-2. Summary of SC&A-Derived External/Internal Dose Estimates ..................................11

Table I-3. Medical X-ray Parameters and Doses ..........................................................................16

Table II-1. Assigned External Doses for Case #[Redacted] .........................................................70

Table II-2. Skin Cancers for Case #[Redacted] ............................................................................71

Table II-3. External Dosimetry Data (mrem) at Y-12 for Case #[Redacted] ...............................72

Table II-4. Assigned External Doses for Case #[Redacted] during Y-12 Employment ...............73

Table II-5. Dose Assignments to the Skin for X-ray Exams Taken at Y-12 ................................79

Table II-6. Assigned External Doses for Case #[Redacted] during X-10 Employment ...............79

Table II-7. Dose Assignments to the Skin for X-ray Exams taken at X-10..................................80

Table II-8. Uranium Bioassay Results (gross alpha) for Case #[Redacted] .................................81

Table II-9. Lung Count Measurements for Case #[Redacted] ......................................................81

Table II-10. Urinalysis Bioassay Analysis....................................................................................82

Table II-11. Calculated Uranium Intakes and Doses using Bioassay Data ..................................83

Table II-12. X-10 Internal Dose Coworker Intakes ......................................................................84

Table II-13. Calculated POC for Skin Cancers for Case #[Redacted] ..........................................84
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

5 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

EXECUTIVE SUMMARY 

Under Contract No. 200-2009-28555, SC&A has been tasked by the Advisory Board on 

Radiation and Worker Health (Advisory Board) to perform eight blind dose reconstructions 

(DRs). This report presents the methodologies and results of our DR concerning one case 

selected by the Advisory Board, which represents a worker employed at the Y-12 Plant and Oak 

Ridge National Laboratory (ORNL), referred to as the X-10 facility. 

To perform this blind DR, SC&A was provided with all of the Department of Energy (DOE) 

dosimetry records; the Department of Labor (DOL) correspondence, forms, and medical records; 

and the Computer-Assisted Telephone Interview (CATI) Report that were made available to 

NIOSH for constructing doses in behalf of this case. SC&A used two independent approaches to 

reconstruct occupational external and internal doses in behalf of this case. Both approaches used 

the available dosimetry records and current guidance from the National Institute for 

Occupational Safety and Health (NIOSH) and its contractor, Oak Ridge Associated Universities 

Team (ORAUT). The first approach, which is referred to as DR–Method A, used the 

spreadsheets and other tools developed by NIOSH to calculate the doses, whereas, the second 

approach, referred to as DR–Method B, manually calculated the doses. 

This Executive Summary provides an overview of the case and a comparison of the results of the 

two independent DR methods. Section I of this report provides a detailed discussion of the 

approach used to reconstruct external/internal occupational radiation doses using DR–Method A, 

and Section II describes the reconstruction of doses using DR–Method B. 

RELEVANT BACKGROUND INFORMATION 

According to the DOL records, this case represents an energy employee (EE) who worked at the 

Y-12 Plant from [redacted], through [redacted], and at the X-10 Plant from [redacted], through 

[redacted]. The EE was diagnosed with eight skin cancers between [redacted] and [redacted], 

as shown in Table ES-1. 

Table ES-1. Cancers and Diagnosis Date 

# Description Diagnosis Date ICD-9 Code

1 SCC [redacted] [redacted] [redacted]

2 SCC [redacted] [redacted] [redacted]

3 BCC [redacted] [redacted] [redacted]

4 BCC [redacted] [redacted] [redacted]

5 BCC [redacted] [redacted] [redacted]

6 BCC [redacted] [redacted] [redacted]

7 SCC [redacted] [redacted] [redacted]

8 SCC [redacted] [redacted] [redacted]

According to the CATI, DOL records, and DOE records, the EE was employed as a [redacted]

at Y-12 and worked predominantly in the [redacted] Lab in Building [redacted]. During 

employment at the X-10 facility, the EE was employed as a [redacted] and worked primarily in 

Building [redacted] ([redacted] Division). DOE records show that the EE was monitored on a 

quarterly basis for external exposure to gamma, beta, and neutron radiation. The EE was 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

6 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

monitored for internal exposure to uranium by means of urinalysis bioassays, and for U-235 and 

thorium by means of lung counts. 

PRESENTATION OF RESULTS

The results of both independent DR methods are shown in Table ES-2. DR–Method A derived 

total skin doses to the various cancer sites ranging from 4.258 rem to 6.782 rem, resulting in a 

probability of causation (POC) of 50.47%; while DR–Method B derived total skin doses ranging 

from 2.782 rem to 7.990 rem resulting in a POC of 52%. 

As shown in Table ES-2, most of the external doses derived by Method A and Method B are 

similar or identical. Two key differences between the two methods are (1) Method A assigned 

an occupational environmental dose for a portion of the EE’s employment at X-10 that was not 

assessed by Method B; and (2) Method B derived a missed shallow dose that may have resulted 

from the direct deposition of uranium dust onto skin/clothing and a missed neutron dose for the 

EE’s employment at Y-12 that were not considered in DR–Method A. The difference in the 

X-10 occupational medical doses between the two methods was the result of Method A assessing 

dose for only the nine x-ray exams identified in the DOE records, while Method B assumed an 

annual x-ray exam for each year of employment at X-10 (i.e., [redacted] through [redacted]).

With regard to internal doses, DR–Method A calculated a significantly higher internal dose for 

the EE’s employment at Y-12, because this method used the lung count data to derive doses for 

exposure to thorium, uranium, and associated radionuclides. Method B calculated dose to only 

U-234 based on urinalyses results. For assessing internal dose during the EE’s employment at 

X-10, both methods assigned coworker dose using guidance in ORAUT-OTIB-0034. The 

differences in dose reflect the decision by Method A to calculate internal dose assuming Type S 

solubility for Sr-90 (and associated radionuclides) and Type Super S (SS) for Pu-239, while 

Method B assumed Type F solubility for Sr-90 and associated radionuclides and Type M 

solubility for all other radionuclides (i.e., U-234, Pu-239 and Am-241). 

A detailed description of the DR approach used by SC&A’s Method A is provided in Section I. 

Section II of this report describes the derivation of external and internal doses using SC&A’s 

DR–Method B. For the benefit of the reader, Table ES-3 also summaries the approach used by 

the two SC&A methods for calculating doses for each of the dose elements considered in this 

DR. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

7 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table ES-2. Derived Dose Estimates 

DR – Method A DR – Method B

(Numbers represent cancers listed in Table ES-1)

#1

Dose

(rem)

#2

Dose

(rem)

#3 &4

Dose

(rem)

#5

Dose

(rem)

#6

Dose

(rem)

#7 

Dose

(rem)

#8

Dose

(rem)

#1

Dose

(rem)

#2

Dose

(rem)

#3 &4

Dose

(rem)

#5

Dose

(rem)

#6

Dose

(rem)

#7 

Dose

(rem)

#8

Dose

(rem)

External Dose (Occupational):*

 ▪ Recorded Photon Dose 

 30–250 keV Photons, Y-12 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142 0.142

 30–250 keV Photons, X-10 0.020 0.020 0.020 0.020 0.020 0.020 0.020 – – – – – – –

 ▪ Missed Photon Dose 

 30–250 keV Photons, Y-12 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165 0.165

 30–250 keV Photons, X-10 0.835 0.835 0.835 0.835 0.835 0.835 0.835 0.920 0.920 0.920 0.920 0.920 0.920 0.920

 ▪ Recorded Shallow Dose

 e

-

>15 keV, Y-12 0.685 0.586 0.685 0.586 0.586 0.685 0.685 0.637 0.545 0.637 0.545 0.637 0.637 0.637

 e

-

>15 keV, X-10 0.070 0.060 0.070 0.060 0.060 0.070 0.070 – – – – – – –

 ▪ Missed Shallow Dose from

 Skin Deposition 

 e- >15 keV, Y-12

– – – – – – – 0.280 0.280 0.280 0.280 0.280 0.280 0.280

 ▪ Missed Neutron Dose

 η 100 keV–2 MeV, Y-12 – – – – – – – 0.224 0.224 0.224 0.224 0.224 0.224 0.224

 ▪ Occupational Medical Dose

 Y-12 0.022 0.824 0.095 0.945 0.021 0.022 0.095 0.026 1.080 0.108 1.080 0.108 0.026 0.108

 X-10 0.049 0.148 0.148 1.479 0.050 0.049 0.148 0.148 0.433 0.433 4.354 0.148 0.148 0.433

 ▪ Occupational Envir. Dose

 Photon, X-10 0.148 0.148 0.148 0.148 0.148 0.148 0.148 – – – – – – –

Internal Dose (Occupational):

 (Method A) Th, U, RU, missed, Y-12

 (Method B) U, Y-12 0.951 1.091 1.148 1.148 1.177 1.177 1.206 0.065 0.073 0.077 0.077 0.078 0.078 0.080

 Coworker, e->15 keV, X-10 0.970 0.973 0.973 0.973 0.973 0.973 0.973 0.045 0.045 0.045 0.045 0.045 0.045 0.045

 Coworker, U-234, X-10 0.001 0.001 0.001 0.001 0.001 0.001 0.001 – – – – – – –

 Coworker, Pu & Am, X-10 0.200 0.256 0.280 0.280 0.291 0.291 0.303 0.130 0.153 0.158 0.158 0.158 0.158 0.160

Total 4.258 5.249 4.710 6.782 4.469 4.578 4.791 2.782 4.060 3.189 7.990 2.905 2.823 3.194
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

8 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table ES-3. Summary of Approach Used by SC&A’s Methods A and B to Calculate 

External and Internal Doses

Dose Element SC&A’s DR-Method A SC&A’s DR-Method B

Y-12 X-10 Y-12 X-10

Recorded Photon 

Dose

Used DOE records, 

Y-12 TBD, and 

ORAUT-OTIB-0017

guidance. Assumed DCF 

= 1 and 100% 30–250 

keV. IREP = Constant 

distribution.

Used DOE records, 

X-10 TBD, and OTIB0017 guidance. 

Assumed DCF = 1;

100% 30–250 keV.

IREP = Constant 

distribution.

Used DOE records, 

Y-12 TBD, OCAS-IG-001 

and OTIB-0017 guidance. 

Assumed DCF = 1 and 

100% 30–250 keV. IREP 

= Normal distribution; 

30% uncertainty.

No recorded doses 

assigned. Based on 

DOE records, all 

doses were 

considered as missed 

photon dose.

Missed Photon 

Dose

Used DOE records to 

identify 11 zero or 

<LOD/2 values; DCF = 

1; 100% 30–250 keV. 

IREP = Lognormal 

distribution with GSD =

1.52 based on OCAS-IG001 guidance.

Used DOE records to 

identify 125 zero or 

<LOD/2 values; DCF = 

1; 100% 30–250 keV. 

IREP = Log-normal 

distribution with 

GSD=1.52 based on 

OCAS-IG-001 guidance.

Used DOE records and 

OTIB-0017 to identify 11 

zero or <LOD/2 values; 

DCF = 1; 100% 30–250 

keV. IREP = Lognormal 

distribution with 

GSD=1.52 based on 

OCAS-IG-001 guidance.

Used DOE records to 

identify 140 zero or 

<LOD/2 values; DCF 

= 1; 100% 30–250 

keV. IREP = Lognormal distribution 

with GSD = 1.52 

based on OCAS-IG001 guidance.

Recorded Shallow 

Dose

Used DOE records, 

Y-12 TBD, and OTIB0017 guidance. Shallow 

minus Deep dose. 

Assumed DCF = 1 and 

100% E>15 keV. IREP = 

Constant distribution.

Used DOE records, 

X-10 TBD, and OTIB0017. Shallow minus 

Deep dose. Assumed 

DCF = 1; 100% E>15 

keV. IREP = Constant 

distribution.

Used DOE records, and 

OTIB-0017 guidance. 

Shallow minus Deep dose. 

Assumed DCF = 1 and 

100% E>15 keV. IREP = 

Normal distribution with 

30% uncertainty.

No recorded doses 

assigned. Based on 

DOE records and 

OTIB-0017, all doses 

were considered 

missed and assigned 

as 30–250 keV under 

missed photon dose.

Missed Shallow 

Dose Not Considered Not Considered

Assumed potential skin 

exposure from direct 

deposition of uranium dust 

on skin/clothing. Dose 

based on EE’s urinalysis 

data.

Not Considered

Missed Neutron 

Dose Not Considered Not Considered

Assigned missed neutron 

doses for zero readings in 

DOE records. Used 

neutron-to-photon ratios 

from Table 6-13 of Y-12 

TBD along with ICRP CF 

of 1.91. IREP = 

Lognormal distribution 

with GSD of 1.52.

Not Considered

Occupational 

Medical Dose

No records. Assumed 

annual x-rays based on 

Y-12 TBD doses and 

PROC-0061 projections. 

IREP = Normal 

distribution with 30% 

uncertainty.

Assumed 9 x-ray exams 

based on DOE records. 

Used X-10 TBD doses 

and ORAUT-PROC0061 projections. IREP 

= Normal distribution 

with 30% uncertainty.

Assumed annual x-rays 

based on Y-12 TBD 

guidance and doses and 

selected body location 

based on ORAUT-OTIB0006 IREP = Normal 

distribution with 30% 

uncertainty.

Assumed annual 

x-rays based on 

Table 3-6 of the X-10 

TBD and guidance in 

ORAUT-OTIB-0006, 

Table A-1. IREP = 

Normal distribution 

with 30% 

uncertainty.

Occupational 

Environmental

Dose

Not Considered

Calculated for 2 

unmonitored years based 

on ORAUT-PROC-0060 

and doses from X-10 

TBD, Attachment 4C

Not Considered Not Considered
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

9 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table ES-3. Summary of Approach Used by SC&A’s Methods A and B to Calculate 

External and Internal Doses

Dose Element SC&A’s DR-Method A SC&A’s DR-Method B

Y-12 X-10 Y-12 X-10

Internal Dose

Calculated thorium and 

U-234 (and associated 

radionuclides) based on 

lung count data. Used 

Y-12 TBD MDA values 

and Type M solubility.

Used coworker model 

(ORAUT-OTIB-0034). 

Calculated Sr-90 (and 

associated radionuclides 

(Type S); U-234 (Type 

M); Pu-239 (Type SS); 

Am-241 (Type M)

Calculated uranium based 

on the EE’s gross alpha 

bioassay results, MDL 

values in Y-12 TBD, and 

guidance in ORAUTOTIB-0060. Assumed 

Type S solubility.

Used coworker 

model (ORAUTOTIB-0034). 

Calculated Sr-90 

(and associated 

radionuclides) 

assuming Type F, 

and Type M 

solubility for U-234, 

Pu-239, and Am-241.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

10 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

SECTION I: DR–METHOD A 

I.1 DOSE RECONSTRUCTION OVERVIEW 

This report presents the results of an independent blind dose reconstruction (DR) performed by 

S. Cohen & Associates (SC&A) for an energy employee (EE) who worked at the National 

Security Complex (Y-12) from [redacted] through [redacted] and the Oak Ridge National 

Laboratory (X-10) from [redacted] to [redacted].

The EE was diagnosed with eight skin cancers of the [redacted] and [redacted] between 

[redacted] and [redacted] [basal cell carcinomas (BCCs) and squamous cell carcinomas

(SCCs)]. All cancers were primary cancers, as shown in Table I-1.

Table I-1. Cancers and Diagnosis Date 

# Description Diagnosis Date ICD-9 Code

1 SCC [redacted] [redacted] [redacted]

2 SCC [redacted] [redacted] [redacted]

3 BCC [redacted] [redacted] [redacted]

4 BCC [redacted] [redacted] [redacted]

5 BCC [redacted] [redacted] [redacted]

6 BCC [redacted] [redacted] [redacted]

7 SCC [redacted] [redacted] [redacted]

8 SCC [redacted] [redacted] [redacted]

According to the Computer-Assisted Telephone Interview (CATI) Report, the EE was an

[redacted] at these facilities. The EE was monitored for external photon and electron exposure 

during most of the employment period at both Y-12 and X-10, and had lung counts at Y-12, but 

only [redacted] bioassay recorded at X-10. 

I.1.1 SC&A Blind DR–Method A Approach 

SC&A reviewed all of the Department of Energy (DOE) records provided on behalf of this 

employee and the NIOSH procedures relevant to this case, which included the Technical Basis 

Documents (TBDs) for Y-12 (ORAUT-TKBS-0014-3, -5, and -6), X-10 (ORAUT-TKBS-0012-

3, -4, -5, and -6); Technical Information Bulletins (TIBs) ORAUT-OTIB-0017 concerning 

shallow doses and ORAUT-OTIB-0006; and ORAUT-PROC-0061 for occupational x-ray doses.

Using the guidance provided in these documents, along with the EE’s dosimetry records, SC&A 

manually calculated reasonable, claimant-favorable annual organ doses for each of the eight 

cancers, as shown in Table I-2. Appendices I.A-1 through I.A-8 provide a list of SC&A’s annual 

organ doses and also include the Interactive RadioEpidemiological Program (IREP) input 

parameters, such as energy range, distribution type, and uncertainty for each year. 

SC&A determined the probability of causation (POC) for this case using annual doses shown in 

Appendices I.A-1 through I.A-8 as input into the IREP program. The total external and internal 

doses shown in Table I-2 produced a POC of 50.47%.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

11 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table I-2. Summary of SC&A-Derived External/Internal Dose Estimates 

#1

IREP 

entry

#1 Dose

(rem)

#2

IREP 

entry

#2

Dose

(rem)

#3, #4, & 

#5

IREP

entry

#3 & #4

Dose

(rem)

#5

Dose

(rem)

#6 & #7

IREP 

entry

#6

Dose

(rem)

#7

Dose

(rem)

#8

IREP

entry

#8

Dose

(rem)

External Dose (Occupational):*

 ▪ Recorded Photon Dose 

 30–250 keV Photons, Y-12 1–2 0.142 1–2 0.142 1–2 0.142 0.142 1–2 0.142 0.142 1–2 0.142

 30–250 keV Photons, X-10 15 0.020 15 0.020 15 0.020 0.020 15 0.020 0.020 15 0.020

 ▪ Missed Photon Dose 

 30–250 keV Photons, Y-12 7–10 0.165 7–10 0.165 7–10 0.165 0.165 7–10 0.165 0.165 7–10 0.165

 30–250 keV Photons, X-10 18–49 0.835 18–49 0.835 18–49 0.835 0.835 18–49 0.835 0.835 18–49 0.835

 ▪ Recorded Shallow Dose

 e

-

>15 keV, Y-12 3–6 0.685 3–6 0.586 3–6 0.685 0.586 3–6 0.586 0.685 3–6 0.685

 e

-

>15 keV, X-10 16–17 0.070 16–17 0.060 16–17 0.070 0.060 16–17 0.060 0.070 16–17 0.070

 ▪ Occupational Medical Dose

 Y-12 11–14 0.022 11–14 0.824 11–14 0.095 0.945 11–14 0.021 0.022 11–14 0.095

 X-10 50–58 0.049 50–58 0.148 50–58 0.148 1.479 50–58 0.050 0.049 50–58 0.148

 ▪ Occupational Envir. Dose

 Photon, X-10 59–60 0.148 59–60 0.148 59–60 0.148 0.148 59–60 0.148 0.148 59–60 0.148

Internal Dose (Occupational):

 Th, U, and RU, missed, Y-12 61–99 0.951 61–104 1.091 61–106 1.148 1.148 61–107 1.177 1.177 61–108 1.206

 Coworker, e->15 keV, X-10 100–135 0.970 105–145 0.973 107–149 0.973 0.973 108–151 0.973 0.973 109–153 0.973

 Coworker, U-234, X-10 136–171 0.001 146–186 0.001 150–192 0.001 0.001 152–195 0.001 0.001 154–198 0.001

 Coworker, Pu & Am, X-10 172–260 0.200 187–290 0.256 193–302 0.280 0.280 196–308 0.291 0.291 199–314 0.303

Total 4.258 5.249 4.710 6.782 4.469 4.578 4.791

*This table is limited to doses reconstructed based on external exposures “at a distance,” as measured by film badges, and does not include skin exposures that may 

have resulted from direct skin contamination. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

12 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

I.2 EXTERNAL DOSES 

To perform this DR, SC&A analyzed the DOE files containing the details of the individual badge 

cycles, and also the summary reports from Y-12 and X-10, and compared them to the External 

Dosimetry Data file supplied to SC&A by NIOSH for this case. The summary reports, the 

individual badge cycle data, and NIOSH’s External Dosimetry Data file agreed with each other. 

In the sections that follow, a description is provided of how SC&A reconstructed the dose 

considering the recorded photon and beta doses and missed doses. 

I.2.1 Recorded Photon and Electron Doses 

The organ dose conversion factor (Organ DCF) of 1.00 was applied to the skin, and all electron 

doses are assumed to be associated with the >15 keV energy range, in accordance with ORAUTOTIB-0017. Because of their location, no clothing attenuation was used for the cancer sites on 

[redacted] (#1, #3, #4, #7, and #8), but a clothing attenuation factor of 0.855 (ORAUT-OTIB0017) was used for the cancer sites on the [redacted], [redacted], and [redacted] (#2, #5, and 

#6). SC&A used 100% AP exposure geometry for recorded and missed dose for this case as per 

ORAUT-TKBS-0014-6 and ORAUT-TKBS-0012-6.

Y-12 Recorded Photon Dose

The DOE records show that this EE was monitored on a quarterly basis for the entire Y-12 

employment period during [redacted]–[redacted], and that the EE received a small amount of 

positive recorded photon and electron dose. SC&A’s Method A used the guidance described in 

Y-12 National Security Complex – Occupational External Dosimetry (ORAUT-TKBS-0014-6) 

and the Technical Information Bulletin: Interpretation of Dosimetry Data for Assignment of 

Shallow Dose (ORAUT-OTIB-0017) in order to derive the organ doses from this exposure. 

Example of [redacted] recorded photon dose calculations: SC&A calculated the [redacted]

photon dose to the skin as follows:

Records show that for [redacted], the EE received a deep dose (D) of 0.027 rem; of which 

0.027 rem was >LOD/2 value of 0.015 rem (ORAUT-TKBS-0014-6, Table 6-3, page 18). 

Skin Dose (30–250 keV) = D × DCF × Energy Fraction (EF) 

= 0.027 × 1.0 × 1.0 

= 0.027 rem 

 

SC&A’s Method A calculated [redacted] 30–250 keV dose of 0.027 rem is listed in entry #1 of 

the IREP Input tables, as shown in each of the Appendices I.A-1 through I.A-8.

The recorded photon doses were entered into IREP as a constant distribution with no uncertainty. 

The total recorded photon dose assignments for the eight cancer sites are summarized in 

Table I-2 above, and detailed in Appendices I.A-1 through I.A-8. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

13 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

X-10 Recorded Photon Dose

The DOE records show that this EE was monitored on a quarterly basis for the entire 

employment period during [redacted]–[redacted] except for [redacted] and [redacted], and the 

EE received mostly zero recorded doses except for a small shallow dose recorded for [redacted] 

and [redacted], and a small deep dose recorded for [redacted]. SC&A used the guidance 

described in the Oak Ridge National Laboratory – Occupational External Dose (ORAUTTKBS-0012-6) and ORAUT-OTIB-0017 in order to derive the organ doses from this exposure. 

Example of [redacted] recorded photon dose calculations: SC&A calculated the [redacted]

photon dose to the skin as follows:

Records show that for [redacted], the EE received a deep dose (D) of 0.020 rem, of which 

0.020 rem was >LOD/2 value of 0.015 rem (ORAUT-TKBS-0012-6, Table 6-24, page 70). 

Skin Dose (30–250 keV) = D × DCF × EF 

= 0.020 × 1.0 × 1.0 

= 0.020 rem 

 

SC&A’s Method A calculated [redacted] 30–250 keV doses of 0.020 rem as listed in entry #15

of the IREP Input tables shown in each of the Appendices I.A-1 through I.A-8.

The recorded photon dose was entered into IREP as a constant distribution with no uncertainty. 

The total recorded photon dose assignments for the eight cancer sites are summarized in 

Table I-2 above and detailed in Appendices I.A-1 through I.A-8. 

Y-12 Recorded Electron Skin Dose

Electron dose was assigned to the skin because of the locations of the cancer sites. The electron 

dose was the difference between the Shallow recorded dose and the Deep recorded dose for both 

the Y-12 and X-10 sites.

Example of [redacted] recorded electron dose calculations: DR–Method A calculated the 

[redacted] electron dose to the skin as follows:

Records show that for [redacted], the EE received a deep dose (D) of 0.011 rem, of which 

0.000 rem was >LOD/2, and a shallow dose of 0.081 rem, of which 0.081 rem was >LOD/2. 

The electron dose to the skin was assumed to be 100% e->15 keV. A skin DCF of 1.0 was 

applied. For cancer sites on the [redacted], [redacted], and [redacted], a clothing 

attenuation factor of 0.855 was also applied.

Unattenuated Electron Skin Dose (>15 keV) = (Shallow – Deep) × DCF 

 = (0.081 rem – 0.000 rem) × 1.0 

 = 0.081 rem 

Attenuated Electron Skin Dose (>15 keV) = (Shallow – Deep) × DCF × Atten. Factor 

 = (0.081 rem – 0.000 rem) × 1.0 × 0.855 

 = 0.069 rem 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

14 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Method A’s calculated [redacted] >15 keV electron skin dose of 0.081 rem is listed in entry #3

of the IREP Input tables shown in Appendices I.A-1, I.A-3, I.A-4, I.A-7, and I.A-8. The 

attenuated skin dose of 0.069 rem is shown in entry #3 of Appendices I.A-2, I.A-5, and I.A-6.

The recorded electron doses were entered into IREP as a constant distribution with no 

uncertainty. The total recorded electron dose assignments for the eight skin cancer sites are 

summarized in Table I-2 above and detailed in Appendices A-1 through A-8.

X-10 Recorded Electron Skin Dose

The measured electron dose for X-10 was calculated similar to the Y-12 electron doses. 

Example of [redacted] recorded electron dose calculations: SC&A calculated the [redacted]

electron dose to the skin as follows:

Records show that for [redacted], the EE received a deep dose (D) of 0.020 rem, of which 

0.020 rem was >LOD/2, and a shallow dose of 0.070 rem, of which 0.070 rem was >LOD/2. 

The electron dose to the skin was assumed to be 100% e->15 keV. A skin DCF of 1.0 was 

applied. For cancer sites on the [redacted], [redacted], and [redacted], a clothing 

attenuation factor of 0.855 was also applied.

Unattenuated Electron Skin Dose (>15 keV) = (Shallow – Deep) × DCF 

 = (0.070 rem – 0.020 rem) × 1.0 

 = 0.050 rem 

Attenuated Electron Skin Dose (>15 keV) = (Shallow – Deep) × DCF × Atten. Factor 

 = (0.070 rem – 0.020 rem) × 1.0 × 0.855 

 = 0.043 rem 

DR–Method A’s calculated [redacted] >15 keV electron skin dose of 0.050 rem is listed in entry 

#17 of the IREP Input tables shown in Appendices I.A-1, I.A-3, I.A-4, I.A-7, and I.A-8. The 

attenuated skin dose of 0.043 rem is shown in entry #17 of Appendices I.A-2, I.A-5, and I.A-6.

The recorded electron doses were entered into IREP as a constant distribution with no 

uncertainty. The total recorded electron dose assignments for the eight skin cancer sites are 

summarized in Table I-2 above, and detailed in Appendices A-1 through A-8.

I.2.2 Missed Photon and Electron Doses 

SC&A analyzed the number of zeros in the EE’s DOE badge cycle data using the guidance in 

OCAS-IG-001, page 16, and a best-estimate reasonable approach, and compared them to those 

provided by the Y-12 Workbook 2.02 and X-10 Workbook 2.04 (which was populated by SC&A 

using the external dose data spreadsheet provided by NIOSH). SC&A arrived at a total of 11 

zeros, or <LOD/2, values for photons at Y-12, and 125 zeros, or <LOD/2, values for photons at 

X-10. SC&A’s numbers and those provided by the workbooks were in agreement. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

15 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Y-12 Missed Photon Dose

SC&A calculated the [redacted] missed photon dose to the skin as follows:

SC&A found [redacted] zeros for [redacted]; i.e., [redacted] readings were recorded that 

were less than the LOD/2. The limit of detection (LOD) for the time period was 0.030 rem, 

making the LOD/2 equal to 0.015 rem.

Missed Skin Photon Dose (30–250 keV) = (# zeros × LOD/2) × DCF 

= (3 × 0.015 rem) × 1.0 

 = 0.045 rem 

SC&A’s calculated 30–250 keV missed photon dose of 0.045 rem is shown in entry #8 of the 

IREP Input tables, as shown in each of the Appendices I.A-1 through I.A-8.

The missed photon doses were entered into IREP as a lognormal distribution with an uncertainty 

of 1.520. The total missed photon dose assignments are summarized in Table I-2 above and 

detailed in Appendices I.A-1 through I.A-8. 

X-10 Missed Photon Dose

SC&A calculated the [redacted] missed photon dose to the skin as follows:

SC&A found [redacted] zeros for [redacted]; i.e., [redacted] readings were recorded that 

were less than the LOD/2. The LOD for the time period was 0.030 rem, making the LOD/2 

equal to 0.015 rem.

Missed Skin Photon Dose (30–250 keV) = (# zeros × LOD/2) × DCF 

= (4 × 0.015 rem) × 1.0 

 = 0.060 rem 

SC&A’s Method A calculated 30–250 keV missed photon dose of 0.060 rem is shown in entry 

#19 of the IREP Input tables, as shown in each of the Appendices, I.A-1 through I.A-8. 

The missed photon doses were entered into IREP as a lognormal distribution with an uncertainty 

of 1.520. The total missed photon dose assignments are summarized in Table I-2 above and 

detailed in Appendices I.A-1 through I.A-8. 

I.2.3 Neutron Dose 

Y-12 Neutron Dose

Although the EE’s records show zero neutron doses for all badged periods at Y-12, the EE most 

likely was not exposed to significant neutrons and no neutron dose should be assigned, as per 

ORAUT-OTIB-0045. 

X-10 Neutron Dose

The EE was not monitored for neutrons at X-10, and considering the EE’s position as an 

engineer and the mostly all zero recorded photon doses, it is likely that the EE was not exposed 

to significant neutron doses. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

16 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

I.2.4 Occupational Medical Dose 

Y-12 X-ray Doses

There were no x-ray exam records in the EE’s files for the Y-12 facility; the EE stated in the 

CATI Report that he had annual x-ray exams. Therefore, ORAUT-TKBS-0014-3, ORAUTOTIB-0006, and ORAUT-PROC-0061 were consulted for the appropriate projections and doses. 

DR–Method A used the projections for the various skin cancer locations recommended in 

Tables C-1, page 16, and C-2, page 19, of ORAUT-PROC-0061, and the corresponding annual 

dose values in Tables A-3 and A-4, pages 22–23, of ORAUT-TKBS-0014-3. These projections 

and doses are summarized in Table I-3. An annual x-ray exam was assumed. 

X-10 X-ray Doses

The DOE records show that the EE received nine PA x-ray exams during the employment period 

of [redacted]–[redacted]. ORAUT-TKBS-0012-3, ORAUT-OTIB-0006, and ORAUT-PROC0061 were consulted for the appropriate projections and doses. SC&A used the projections for 

the various skin cancer locations recommended in Tables C-1, page 16, and C-2, page 19, of 

ORAUT-PROC-0061, and the corresponding annual dose values in Table 3-6, page 23, of 

ORAUT-TKBS-0012-3. These projections and doses are summarized in Table I-3. 

Table I-3. Medical X-ray Parameters and Doses 

#

Description Diagnosis 

Date

PROC-61

Projection

Y-12 Total

Dose (rem)

X-10 Total 

Dose (rem)

1 SCC [redacted] [redacted] [redacted] 0.022 0.049

2 SCC [redacted] [redacted] [redacted] 0.824 0.148

3 BCC [redacted] [redacted] [redacted] 0.095 0.148

4 BCC [redacted] [redacted] [redacted] 0.095 0.148

5 BCC [redacted] [redacted] [redacted] 0.945 1.479

6 BCC [redacted] [redacted] [redacted] 0.021 0.050

7 SCC [redacted] [redacted] [redacted] 0.022 0.049

8 SCC [redacted] [redacted] [redacted] 0.095 0.148

The annual occupational medical dose values were entered into IREP as a normal distribution 

with 30% uncertainty and a photon energy range of 30–250 keV. 

I.2.5 Onsite Ambient Dose 

Y-12

SC&A’s DR–Method A found that the EE was monitored for all periods during the Y-12

employment; therefore, according to ORAUT-PROC-0060, Attachment A, page 14, no external 

ambient dose should be assigned in this case. 

X-10

DR–Method A found that the EE was monitored for most periods during the X-10 employment 

except during the years [redacted] and [redacted], for which the EE’s DOE files were blank. 

Therefore, according to ORAUT-PROC-0060, Attachment A, page 14, no external ambient dose 

should be assigned, except for these 2 years. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

17 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

DR–Method A assigned environmental ambient doses for the two unmonitored years using the 

mrem per hours dose values recommended in Attachment 4C, page 41, of ORAUT-TKBS-0012-

4, adjusting for 2,500 hr/year, and arrived at a total external ambient dose of 0.073 rem for 

[redacted] and 0.075 rem for [redacted]. These dose values are assigned in entries #59 and 

#60, respectively, of the IREP Input tables, as shown in Appendices I.A-1 through I.A-8. 

I.3 INTERNAL DOSES 

The EE had annual recorded lung counts at Y-12 and one whole body count at X-10. 

I.3.1 Y-12 Internal Thorium and Uranium Doses 

The EE was bioassayed yearly for thorium and uranium by lung counts at Y-12, with the last 

lung count performed on [redacted]; all results were less than the minimum detection activity 

(MDA). 

Thorium

Th-232 

DR–Method A used one-half of the Th-232 MDA value of 0.6 nCi from ORAUT-TKBS-0014-5, 

page 34, on [redacted], in the Integrated Modules of Bioassay Analysis (IMBA) program to 

project a chronic intake during the period [redacted], through [redacted], of 100.9 dpm/d of 

Type M Th-232; Type S Th-232 was projected to be 26.14 dpm/d. These intakes were entered 

into the chronic annual dose workbook (CADW) to determine the dose to the skin. 

Th-228 

SC&A’s Method A used the recommended Th-228/Th-232 value of 0.8 found on page 34 of 

ORAUT-TKBS-0014-5 to arrive at a potential intake of 80.72 dpm/d of Type M, and 

20.912 dpm/d of Type S Th-228. These intakes were entered into the CADW to determine the 

dose to the skin. 

U-234 and Associated Radionuclides

SC&A’s Method A used one-half of the U-235 MDA value of 360 dpm from ORAUT-TKBS0014-5, Table 5-11, page 33, as U-234 (because it is claimant favorable) in the IMBA program 

to project a chronic intake during the period [redacted], through [redacted], of 27.277 dpm/d of 

Type M U-234. Type S U-234 was projected to be 7.065 dpm/d. These intakes were entered 

into the CADW to determine the dose to the skin. 

Np-237 was also analyzed using the lung counts, with an MDA of 0.255 nCi, from ORAUTTKB-0014-5, page 34. This was also analyzed using the IMBA program with a projected intake 

of 283.0 dpm of Type M Np-237. This was also entered into the CADW to determine the dose 

to the skin. 

Recycled uranium was potentially present; therefore, it was accounted for by using the default 

very highly enriched uranium (VHEU) and Oralloy uranium ratio values recommended in 

Table 5-8, page 22, of ORAUT-TKBS-0014-5. Technetium-99 was the only electron emitter 

present; the total dose was <0.001 rem/year and not included in the IREP Input tables. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

18 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

The total alpha doses from these radionuclides were summed and listed in the IREP Input tables, 

starting with entry #61, for each cancer site. It was found that Type M provided for the greater 

dose for each of the radionuclides; therefore, dose from Type M solubility was used. 

Observation: 

SC&A has analyzed the use of lung counts at Y-12 to project thorium intake as recommended in 

ORAUT-TKBS-0014-5 and OCAS-PER-031 and found that the recommended method is not 

technically sound; SC&A provided a report to NIOSH, which details our concerns, on July 15, 

2013. It should also be noted that Y-12 chest count data are identical to those deemed 

inadequate for DR at Fernald, which provided the basis for awarding an SEC at Fernald for 

1968–1978.

I.3.2 X-10 Internal Doses 

The EE had only one whole-body count at X-10 on [redacted], with all radionuclides below the 

MDA values. Because the EE was continuously monitored for external exposures, there was a 

potential for internal exposure; therefore, DR–Method A assigned coworker intakes in this case. 

If the EE had only been occasionally monitored for external exposure, then environmental 

intakes may have been appropriate. SC&A’s Method A used the recommended coworker intakes 

in ORAUT-OTIB-0034 for Sr-90 (and related radionuclides), U-234, Pu-239, and Am-241.

Sr-90 and Associated Radionuclides

Method A used the coworker Sr-90 intake values recommended in Tables 5-1 and 5-2, page 10, 

of ORAUT-OTIB-0034 for Type F and Type S Sr-90 (along with the intake values for associated 

radionuclides of Ru-106, Cs-137, and Ce-144 determined by using the Sr-90 ratios from 

Table 5-7, page 15 of ORAUT-OTIB-0034) in the CADW to derive the dose to the skin. As per 

Section 5.2, page 11, of ORAUT-TKBS-0014-5, SC&A compared the dose derived from 

Type M and Type S Sr-90 and found that Type S provided for the greater dose to the skin. The 

annual doses from these electron emitters were entered into the IREP program as e- >15 keV, 

with a lognormal distribution, and a geometric standard deviation (GSD) of 3.00. The total dose 

ranged between 0.970 rem and 0.973 rem, depending on the cancer and the year it was 

diagnosed. 

U-234

Method A used the coworker U-234 intake values recommended in Table 5-3, page 11, of 

ORAUT-OTIB-0034 for Type F and Type M U-234 in the CADW to derive the dose to the skin. 

SC&A compared the dose derived from Type F and Type M U-234 and found that Type M 

provided for the greater dose to the skin. The annual alpha dose was entered into the IREP 

program, with a lognormal distribution, and a GSD of 3.33. The total dose was approximately 

0.001 rem to each cancer site. 

Pu-239 and Am-241

SC&A’s DR–Method A used the coworker Pu-239 intake values recommended in Table 5-4, 

page 12, of ORAUT-OTIB-0034 for Type M and Type S Pu-239 in the CADW to derive the 

dose to the skin. SC&A compared the dose derived from Type M and Type S Pu-239 and found 

that Type S provided for the greater dose to the skin. The annual doses from Type S Pu-239 

were appropriately adjusted by using ORAUT-OTIB-0049 for Type SS plutonium. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

19 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Method A used the coworker Am-241 intake values recommended in Table 5-6, page 13, of 

ORAUT-OTIB-0034 for Type M in the CADW to derive the dose to the skin. 

The total Pu-239 and Am-241 annual alpha doses were entered into the IREP program with a 

lognormal distribution. The total dose ranged from 0.230 rem to 0.303 rem, depending on the 

cancer and year it was diagnosed. 

I.3.3 Environmental Internal Dose 

Because the EE was assigned missed internal dose for Y-12 and coworker dose for X-10, no 

environmental internal dose was assigned. 

I.4 CATI REPORT AND RADIOLOGICAL INCIDENTS 

SC&A’s DR–Method A reviewed the EE’s DOE records and CATI Report to determine if the 

EE was involved in any radiological incidents. Method A did not find any documentation of 

radiological incidents that would impact the external radiation doses assigned in this case.

I.5 SUMMARY CONCLUSIONS 

This DR used best-estimate methods to obtain reasonable external and internal dose assignments. 

These derived doses provided for a POC >50. 

The total POC for the eight multiple primary cancers was calculated using the IREP (v.5.7) and 

was determined to be 50.47%. 

I.6 REFERENCES 

OCAS-IG-001. 2007. External Dose Reconstruction Implementation Guideline, Rev. 3, 

National Institute for Occupational Safety and Health, Office of Compensation Analysis and 

Support, Cincinnati, Ohio. November 21, 2007. 

OCAS-PER-031. 2007. Y-12 TBD Revisions, Rev. 00, National Institute for Occupational 

Safety and Health, Office of Compensation Analysis and Support, Cincinnati, Ohio. December 

18, 2007. 

ORAUT-OTIB-0006. 2011. Dose Reconstruction from Occupationally Medical X-ray 

Procedures, Rev. 04, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 20, 

2011.

ORAUT-OTIB-0017. 2005. Technical Information Bulletin: Interpretation of Dosimetry Data 

for Assignment of Shallow Dose, Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, 

Ohio. October 11, 2005. 

ORAUT-OTIB-0034. 2011. Technical Information Bulletin: Internal Dosimetry Coworker 

Data for X-10, Rev. 01, Oak Ridge Associated Universities, Cincinnati, Ohio. April 23, 2013. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

20 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

ORAUT-OTIB-0045. 2009. Technical Information Bulletin: Historical Evaluation of the Film 

Badge Dosimetry Program at the Y-12 Plant in Oak Ridge, Tennessee: Part 2–Neutron 

Radiation, Rev. 01, Oak Ridge Associated Universities, Cincinnati, Ohio. November 30, 2009. 

ORAUT-OTIB-0049. 2010. Technical Information Bulletin: Estimating Doses for Plutonium 

Strongly Retained in the Lung, Rev. 01 PC-2, Oak Ridge Associated Universities, Cincinnati, 

Ohio. November 29, 2010. 

ORAUT-PROC-0060. 2006. Occupational On-Site Ambient Dose Reconstruction for DOE 

Sites, Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 28, 2006. 

ORAUT-PROC-0061. 2010. Occupational X-Ray Dose Reconstruction for DOE Sites, Rev. 03, 

Oak Ridge Associated Universities Team, Cincinnati, Ohio. March 3, 2010. 

ORAUT-TKBS-0012-3. 2007. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational Medical Dose, Rev. 02, Oak Ridge Associated Universities, 

Cincinnati, Ohio. October 1, 2007. 

ORAUT-TKBS-0012-4. 2004. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational Environmental Dose, Rev. 00, Oak Ridge Associated Universities, 

Cincinnati, Ohio. May 7, 2004. 

ORAUT-TKBS-0012-5. 2013. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational Internal Dose, Rev. 02, Oak Ridge Associated Universities, 

Cincinnati, Ohio. February 8, 2013.

ORAUT-TKBS-0012-6. 2007. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational External Dose, Rev. 01, Oak Ridge Associated Universities, 

Cincinnati, Ohio. September 10, 2007.

ORAUT-TKBS-0014-3. 2007. Technical Basis Document for the Y-12 National Security 

Complex – Occupational Medical Dose, Rev. 01, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. June 18, 2007. 

ORAUT-TKBS-0014-5. 2012. Technical Basis Document for the Y-12 National Security 

Complex – Occupational Internal Dose, Rev. 03, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. March 12, 2012. 

ORAUT-TKBS-0014-6. 2009. Technical Basis Document for the Y-12 National Security 

Complex – Occupational External Dose, Rev. 02, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. December 18, 2009. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

21 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-1: IREP INPUT – SCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

260

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type Parameter 1 Parameter 2 Parameter 3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.081 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.269 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.291 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.044 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

12 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

13 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

14 [redacted] acute photons E=30-250keV Normal 0.003 0.001 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.020 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.050 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

22 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-1: IREP Input – SCC [Redacted] (continued)

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

51 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

52 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

53 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

54 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

55 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

56 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

57 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

58 [redacted] acute photons E=30-250keV Normal 0.001 0.000 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

23 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-1: IREP Input – SCC [Redacted] (continued)

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

101 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

102 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

103 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

104 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

105 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

106 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

107 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

108 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

24 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-1: IREP Input – SCC [Redacted] (continued)

136 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

137 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

138 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

139 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

140 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

141 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

142 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

143 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

144 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

145 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

146 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

147 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

148 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

149 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

150 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

151 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

175 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

176 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

177 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

178 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

179 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

180 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

181 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

182 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

25 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-1: IREP Input – SCC [Redacted] (continued)

183 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

184 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

185 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

186 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

187 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

188 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

189 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

190 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

191 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

192 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

193 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

194 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

195 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

196 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

209 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

210 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

211 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

212 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

216 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

217 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

218 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

219 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

220 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

221 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

222 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

223 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

224 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

225 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

226 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

227 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

228 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

229 [redacted] chronic alpha Lognormal 0.005 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

26 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-1: IREP Input – SCC [Redacted] (continued)

230 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

231 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

232 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

233 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

234 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

235 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

236 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

237 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

238 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

239 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

240 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

27 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-2: IREP INPUT – SCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

290

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.069 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.230 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.249 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.038 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

12 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

13 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

14 [redacted] acute photons E=30-250keV Normal 0.014 0.004 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.017 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.043 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

28 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

51 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

52 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

53 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

54 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

55 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

56 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

57 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

58 [redacted] acute photons E=30-250keV Normal 0.003 0.009 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

29 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

106 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

107 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

108 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

30 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

146 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

147 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

148 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

149 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

150 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

151 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

31 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

190 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

191 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

192 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

193 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

194 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

195 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

196 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

229 [redacted] chronic alpha Lognormal 0.000 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

32 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

230 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

231 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

232 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

236 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

237 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

238 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

239 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

240 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.002 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

33 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-2: IREP Input – SCC [Redacted] (continued)

277 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

278 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

279 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

34 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDICES A-3 AND A-4: IREP INPUT – BCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

302

Exposure #

Exposure 

Year

Exposure 

Rate Radiation Type

Dose Distribution 

Type Parameter 1 Parameter 2 Parameter 3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.081 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.269 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.291 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.044 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

12 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

13 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

14 [redacted] acute photons E=30-250keV Normal 0.014 0.004 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.020 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.050 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

35 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

51 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

52 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

53 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

54 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

55 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

56 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

57 [redacted] acute photons E=30-250keV Normal 0.018 0.054 0.000

58 [redacted] acute photons E=30-250keV Normal 0.003 0.009 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

36 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic alpha Triangular 0.000 0.028 0.057

106 [redacted] chronic alpha Triangular 0.000 0.029 0.057

107 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

108 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

37 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

146 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

147 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

148 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

149 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

150 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

151 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

38 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

190 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

191 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

192 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

193 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

194 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

195 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

196 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

229 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

39 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

230 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

231 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

232 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

236 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

237 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

238 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

239 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

240 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.007 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

40 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendices A-3 and A-4: IREP Input – BCC [Redacted] (continued)

277 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

278 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

279 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

291 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

292 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

293 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

294 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

295 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

296 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

297 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

298 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

299 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

300 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

301 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

302 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

41 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-5: IREP INPUT – BCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

302

Exposure #

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type Parameter 1 Parameter 2 Parameter 3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.069 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.230 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.249 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.038 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

12 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

13 [redacted] acute photons E=30-250keV Normal 0.270 0.081 0.000

14 [redacted] acute photons E=30-250keV Normal 0.135 0.041 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.017 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.043 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

42 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

51 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

52 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

53 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

54 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

55 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

56 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

57 [redacted] acute photons E=30-250keV Normal 0.181 0.054 0.000

58 [redacted] acute photons E=30-250keV Normal 0.031 0.009 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

43 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic alpha Triangular 0.000 0.028 0.057

106 [redacted] chronic alpha Triangular 0.000 0.029 0.057

107 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

108 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

44 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

146 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

147 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

148 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

149 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

150 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

151 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

45 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

190 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

191 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

192 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

193 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

194 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

195 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

196 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

229 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

230 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

46 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

231 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

232 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

236 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

237 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

238 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

239 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

240 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

277 [redacted] chronic alpha Lognormal 0.007 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

47 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-5: IREP Input – BCC [Redacted] (continued)

278 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

279 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

291 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

292 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

293 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

294 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

295 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

296 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

297 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

298 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

299 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

300 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

301 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

302 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

48 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-6: IREP INPUT – BCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

308

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.069 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.230 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.249 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.038 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

12 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

13 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

14 [redacted] acute photons E=30-250keV Normal 0.003 0.001 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.017 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.043 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

49 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

51 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

52 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

53 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

54 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

55 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

56 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

57 [redacted] acute photons E=30-250keV Normal 0.006 0.054 0.000

58 [redacted] acute photons E=30-250keV Normal 0.003 0.009 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

50 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic alpha Triangular 0.000 0.028 0.057

106 [redacted] chronic alpha Triangular 0.000 0.029 0.057

107 [redacted] chronic alpha Triangular 0.000 0.029 0.057

108 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

51 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

146 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

147 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

148 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

149 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

150 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

151 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

52 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

190 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

191 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

192 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

193 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

194 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

195 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

196 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

229 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

230 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

53 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

231 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

232 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

236 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

237 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

238 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

239 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

240 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

277 [redacted] chronic alpha Lognormal 0.006 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

54 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-6: IREP Input – BCC [Redacted] (continued)

278 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

279 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

291 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

292 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

293 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

294 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

295 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

296 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

297 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

298 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

299 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

300 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

301 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

302 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

303 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

304 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

305 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

306 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

307 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

308 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

55 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-7: IREP INPUT – SCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

308

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2

Parameter 

3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.081 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.269 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.291 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.044 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

12 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

13 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

14 [redacted] acute photons E=30-250keV Normal 0.003 0.001 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.020 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.050 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

56 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

51 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

52 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

53 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

54 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

55 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

56 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

57 [redacted] acute photons E=30-250keV Normal 0.006 0.002 0.000

58 [redacted] acute photons E=30-250keV Normal 0.001 0.000 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

57 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic alpha Triangular 0.000 0.028 0.057

106 [redacted] chronic alpha Triangular 0.000 0.029 0.057

107 [redacted] chronic alpha Triangular 0.000 0.029 0.057

108 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

109 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

58 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

146 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

147 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

148 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

149 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

150 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

151 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

152 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

153 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

59 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

190 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

191 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

192 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

193 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

194 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

195 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

196 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

197 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

198 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

199 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

229 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

230 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

60 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

231 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

232 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

236 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

237 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

238 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

239 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

240 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

241 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

242 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

243 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

244 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

277 [redacted] chronic alpha Lognormal 0.006 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

61 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-7: IREP Input – SCC [Redacted] (continued)

278 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

279 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

291 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

292 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

293 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

294 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

295 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

296 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

297 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

298 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

299 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

300 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

301 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

302 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

303 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

304 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

305 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

306 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

307 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

308 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

62 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX A-8: IREP INPUT – SCC [REDACTED]

EXPOSURE INFORMATION

Number of exposures

314

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 

2 Parameter 3

1 [redacted] acute photons E=30-250keV Constant 0.027 0.000 0.000

2 [redacted] acute photons E=30-250keV Constant 0.115 0.000 0.000

3 [redacted] acute electrons E>15keV Constant 0.081 0.000 0.000

4 [redacted] acute electrons E>15keV Constant 0.269 0.000 0.000

5 [redacted] acute electrons E>15keV Constant 0.291 0.000 0.000

6 [redacted] acute electrons E>15keV Constant 0.044 0.000 0.000

7 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

8 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

9 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

10 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

11 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

12 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

13 [redacted] acute photons E=30-250keV Normal 0.027 0.008 0.000

14 [redacted] acute photons E=30-250keV Normal 0.014 0.004 0.000

15 [redacted] acute photons E=30-250keV Constant 0.020 0.000 0.000

16 [redacted] acute electrons E>15keV Constant 0.020 0.000 0.000

17 [redacted] acute electrons E>15keV Constant 0.050 0.000 0.000

18 [redacted] acute photons E=30-250keV Lognormal 0.030 1.520 0.000

19 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

20 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

21 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

22 [redacted] acute photons E=30-250keV Lognormal 0.060 1.520 0.000

23 [redacted] acute photons E=30-250keV Lognormal 0.045 1.520 0.000

24 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

25 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

26 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

27 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

28 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

29 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

30 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

31 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

32 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

33 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

34 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

35 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

36 [redacted] acute photons E=30-250keV Lognormal 0.025 1.520 0.000

37 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

38 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

39 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

40 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

41 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

42 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

63 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

43 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

44 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

45 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

46 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

47 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

48 [redacted] acute photons E=30-250keV Lognormal 0.020 1.520 0.000

49 [redacted] acute photons E=30-250keV Lognormal 0.015 1.520 0.000

50 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

51 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

52 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

53 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

54 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

55 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

56 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

57 [redacted] acute photons E=30-250keV Normal 0.018 0.002 0.000

58 [redacted] acute photons E=30-250keV Normal 0.003 0.000 0.000

59 [redacted] chronic photons E=30-250keV Lognormal 0.073 3.000 0.000

60 [redacted] chronic photons E=30-250keV Lognormal 0.075 3.000 0.000

61 [redacted] chronic alpha Triangular 0.000 0.007 0.014

62 [redacted] chronic alpha Triangular 0.000 0.021 0.042

63 [redacted] chronic alpha Triangular 0.000 0.032 0.064

64 [redacted] chronic alpha Triangular 0.000 0.040 0.080

65 [redacted] chronic alpha Triangular 0.000 0.040 0.079

66 [redacted] chronic alpha Triangular 0.000 0.032 0.063

67 [redacted] chronic alpha Triangular 0.000 0.026 0.052

68 [redacted] chronic alpha Triangular 0.000 0.023 0.046

69 [redacted] chronic alpha Triangular 0.000 0.021 0.042

70 [redacted] chronic alpha Triangular 0.000 0.020 0.040

71 [redacted] chronic alpha Triangular 0.000 0.020 0.039

72 [redacted] chronic alpha Triangular 0.000 0.020 0.039

73 [redacted] chronic alpha Triangular 0.000 0.020 0.039

74 [redacted] chronic alpha Triangular 0.000 0.020 0.040

75 [redacted] chronic alpha Triangular 0.000 0.020 0.041

76 [redacted] chronic alpha Triangular 0.000 0.021 0.042

77 [redacted] chronic alpha Triangular 0.000 0.021 0.042

78 [redacted] chronic alpha Triangular 0.000 0.022 0.043

79 [redacted] chronic alpha Triangular 0.000 0.022 0.044

80 [redacted] chronic alpha Triangular 0.000 0.022 0.045

81 [redacted] chronic alpha Triangular 0.000 0.023 0.046

82 [redacted] chronic alpha Triangular 0.000 0.023 0.046

83 [redacted] chronic alpha Triangular 0.000 0.024 0.047

84 [redacted] chronic alpha Triangular 0.000 0.024 0.048

85 [redacted] chronic alpha Triangular 0.000 0.024 0.048

86 [redacted] chronic alpha Triangular 0.000 0.024 0.049

87 [redacted] chronic alpha Triangular 0.000 0.025 0.050

88 [redacted] chronic alpha Triangular 0.000 0.025 0.050

89 [redacted] chronic alpha Triangular 0.000 0.025 0.051
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

64 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

90 [redacted] chronic alpha Triangular 0.000 0.026 0.051

91 [redacted] chronic alpha Triangular 0.000 0.026 0.052

92 [redacted] chronic alpha Triangular 0.000 0.026 0.052

93 [redacted] chronic alpha Triangular 0.000 0.026 0.052

94 [redacted] chronic alpha Triangular 0.000 0.026 0.053

95 [redacted] chronic alpha Triangular 0.000 0.027 0.053

96 [redacted] chronic alpha Triangular 0.000 0.027 0.054

97 [redacted] chronic alpha Triangular 0.000 0.027 0.054

98 [redacted] chronic alpha Triangular 0.000 0.027 0.054

99 [redacted] chronic alpha Triangular 0.000 0.027 0.055

100 [redacted] chronic alpha Triangular 0.000 0.028 0.055

101 [redacted] chronic alpha Triangular 0.000 0.028 0.056

102 [redacted] chronic alpha Triangular 0.000 0.028 0.056

103 [redacted] chronic alpha Triangular 0.000 0.028 0.056

104 [redacted] chronic alpha Triangular 0.000 0.028 0.057

105 [redacted] chronic alpha Triangular 0.000 0.028 0.057

106 [redacted] chronic alpha Triangular 0.000 0.029 0.057

107 [redacted] chronic alpha Triangular 0.000 0.029 0.057

108 [redacted] chronic alpha Triangular 0.000 0.029 0.058

109 [redacted] chronic electrons E>15keV Lognormal 0.018 3.000 0.000

110 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

111 [redacted] chronic electrons E>15keV Lognormal 0.036 3.000 0.000

112 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

113 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

114 [redacted] chronic electrons E>15keV Lognormal 0.038 3.000 0.000

115 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

116 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

117 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

118 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

119 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

120 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

121 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

122 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

123 [redacted] chronic electrons E>15keV Lognormal 0.039 3.000 0.000

124 [redacted] chronic electrons E>15keV Lognormal 0.031 3.000 0.000

125 [redacted] chronic electrons E>15keV Lognormal 0.024 3.000 0.000

126 [redacted] chronic electrons E>15keV Lognormal 0.022 3.000 0.000

127 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

128 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

129 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

130 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

131 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

132 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

133 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

134 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

135 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

136 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

137 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

65 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

138 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

139 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

140 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

141 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

142 [redacted] chronic electrons E>15keV Lognormal 0.021 3.000 0.000

143 [redacted] chronic electrons E>15keV Lognormal 0.011 3.000 0.000

144 [redacted] chronic electrons E>15keV Lognormal 0.004 3.000 0.000

145 [redacted] chronic electrons E>15keV Lognormal 0.002 3.000 0.000

146 [redacted] chronic electrons E>15keV Lognormal 0.001 3.000 0.000

147 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

148 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

149 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

150 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

151 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

152 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

153 [redacted] chronic electrons E>15keV Lognormal 0.000 3.000 0.000

154 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

155 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

156 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

157 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

158 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

159 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

160 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

161 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

162 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

163 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

164 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

165 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

166 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

167 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

168 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

169 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

170 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

171 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

172 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

173 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

174 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

175 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

176 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

177 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

178 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

179 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

180 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

181 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

182 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

183 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

184 [redacted] chronic alpha Lognormal 0.000 3.330 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

66 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

185 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

186 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

187 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

188 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

189 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

190 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

191 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

192 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

193 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

194 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

195 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

196 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

197 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

198 [redacted] chronic alpha Lognormal 0.000 3.330 0.000

199 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

200 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

201 [redacted] chronic alpha Lognormal 0.000 3.400 0.000

202 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

203 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

204 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

205 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

206 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

207 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

208 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

209 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

210 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

211 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

212 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

213 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

214 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

215 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

216 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

217 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

218 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

219 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

220 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

221 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

222 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

223 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

224 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

225 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

226 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

227 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

228 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

229 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

230 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

231 [redacted] chronic alpha Lognormal 0.001 3.400 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

67 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

232 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

233 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

234 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

235 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

236 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

237 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

238 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

239 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

240 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

241 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

242 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

243 [redacted] chronic alpha Lognormal 0.001 3.400 0.000

244 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

245 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

246 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

247 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

248 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

249 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

250 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

251 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

252 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

253 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

254 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

255 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

256 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

257 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

258 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

259 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

260 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

261 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

262 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

263 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

264 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

265 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

266 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

267 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

268 [redacted] chronic alpha Lognormal 0.005 3.000 0.000

269 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

270 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

271 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

272 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

273 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

274 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

275 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

276 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

277 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

278 [redacted] chronic alpha Lognormal 0.006 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

68 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix A-8: IREP Input – SCC [Redacted] (continued)

279 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

280 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

281 [redacted] chronic alpha Lognormal 0.006 3.000 0.000

282 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

283 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

284 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

285 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

286 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

287 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

288 [redacted] chronic alpha Lognormal 0.007 3.000 0.000

289 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

290 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

291 [redacted] chronic alpha Lognormal 0.000 3.000 0.000

292 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

293 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

294 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

295 [redacted] chronic alpha Lognormal 0.001 3.000 0.000

296 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

297 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

298 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

299 [redacted] chronic alpha Lognormal 0.002 3.000 0.000

300 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

301 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

302 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

303 [redacted] chronic alpha Lognormal 0.003 3.000 0.000

304 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

305 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

306 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

307 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

308 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

309 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

310 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

311 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

312 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

313 [redacted] chronic alpha Lognormal 0.004 3.000 0.000

314 [redacted] chronic alpha Lognormal 0.004 3.000 0.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

69 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

SECTION II: DR–METHOD B 

II.1 DOSE RECONSTRUCTION OVERVIEW 

Section II of this report presents the methodologies and results of our blind DR for Case 

#[redacted] representing an EE that worked at Y-12 and the X-10. The EE contracted eight skin 

cancers (SCCs and BCCs) of the [redacted], [redacted], and [redacted]. This EE was 

monitored under an external monitoring program, which included recorded photon, beta, and 

neutron exposures. The EE was also monitored for internal exposures during employment at 

Y-12, but was not monitored for internal exposures while at X-10. 

Our investigation evaluated recorded and missed dose to external penetrating and nonpenetrating radiation based on film badge and thermoluminescent dosimeter (TLD) data, 

potential neutron exposures, occupational medical dose, missed dose from skin deposition of 

radioactive dust, and recorded and missed internal dose. The shallow dose calculation, which 

will be discussed below, takes into consideration attenuation of the beta radiation from clothing. 

The following table summarizes our estimate of the worker’s skin dose. 

Based on these results, DR–Method B derived a POC of 52%.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

70 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table II-1. Assigned External Doses for Case #[Redacted]

Radiation Type

Appendix 

II.A-1 

Exposure 

No.

SCC 

[redact]

(rem)

Appendix 

II.A-2 

Exposure 

No.

SCC 

[redact]

(rem)

Appendix 

II.A-3

Exposure 

No.

BCC 

[redact]

(rem)

Appendix 

A-4

Exposure 

No.

BCC 

[redact]

(rem)

Appendix 

II.A-5 

Exposure 

No.

BCC 

[redact]

(rem)

Appendix 

II.A-6

Exposure 

No.

SCC 

[redact]

(rem)

Appendix 

II.A-7

Exposure 

No.

SCC

[redact]

(rem)

Recorded photon (Y-12) 1–2 0.142 1–2 0.142 1–2 0.142 1–2 0.142 1–2 0.142 1–2 0.142 1–2 0.142

Recorded shallow (Y-12) 3–6 0.637 3–6 0.545 3–6 0.637 3–6 0.545 3–6 0.637 3–6 0.637 3–6 0.637

Missed photon (Y-12) 7–10 0.165 7–10 0.165 7–10 0.165 7–10 0.165 7–10 0.165 7–10 0.165 7–10 0.165

Missed photon (X-10) 15–48 0.920 15–48 0.920 15–48 0.920 15–48 0.920 15–48 0.920 15–48 0.920 15–48 0.920

Missed neutron (Y-12) 11–14 0.224 11–14 0.224 11–14 0.224 11–14 0.224 11–14 0.224 11–14 0.224 11–14 0.224

Occupational medical (Y12) 49–52 0.026 49–52 1.080 49–52 0.108 49–52 1.080 49–52 0.108 49–52 0.026 49–52 0.108

Missed dose from skin 

deposition (Y-12) 53–56 0.280 53–56 0.280 53–56 0.280 53–56 0.280 53–56 0.280 53–56 0.280 53–56 0.280

Internal dose (Y-12) 57–95 0.065 57–100 0.070 57–102 0.073 57–102 0.073 57–103 0.074 57–103 0.074 57–104 0.075

Internal dose Pu (X-10) 96– 131 0.070 101– 141 0.081 103–145 0.083 103–145 0.083 104–147 0.084 104–147 0.084 105–149 0.085

Internal dose Am (X-10) 132–167 0.060 142–182 0.072 146–188 0.075 146–188 0.075 148–191 0.076 148–191 0.076 150–194 0.077

Occupational medical (X10) 168–201 0.148 183–216 0.433 189–222 0.433 189–222 4.354 192–225 0.148 192–225 0.148 195–228 0.433

Total 2.74 4.01 3.14 7.94 2.86 2.77 3.15
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

71 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

II.2 RELEVANT BACKGROUND INFORMATION

According to the DOE records, the EE worked as a [redacted] at the Y-12 plant from 

[redacted], through [redacted]. The EE then worked as a [redacted] at the X-10 plant from 

[redacted], through [redacted]. The EE was diagnosed with eight SCCs and BCCs between 

[redacted] and [redacted], as listed in Table II-2.

Table II-2. Skin Cancers for Case #[Redacted]

Date of Diagnosis Skin Cancer Type Location

[redacted] SCC in situ [redacted]

[redacted] SCC in situ [redacted]

[redacted] BCC [redacted]

[redacted] BCC [redacted]

[redacted] BCC [redacted]

[redacted] BCC [redacted]

[redacted] SCC in situ [redacted]

[redacted] SCC [redacted]

At the present time, there are two Special Exposure Cohorts (SECs) that pertain to the Y-12 site, 

which cover the years 1943–1957. This claim is not eligible for compensation under those 

SECs, due to the fact that skin cancers are not included in the cohort, and the EE’s employment 

period is not within the time period covered by the SEC. 

Y-12 Employment

As a [redacted] at Y-12, the EE worked predominantly in the [redacted] Lab in Building 

[redacted]. In the CATI Report, the EE indicates being exposed to enriched uranium, and 

sometimes wore a respirator for the [redacted]. In the DOE records, the EE describes the work 

at Y-12:

[Redacted]. I feel I was exposed to a number of solvents and chemicals. I had a 

lot of [redacted] exposures, toxic.

The DOE records show that the EE was monitored on a quarterly basis for external exposure to 

gamma, beta, and neutron radiation. The EE was monitored for internal exposure to uranium by 

means of urinalysis bioassays. The EE was also monitored for U-235 and thorium by means of 

chest counts. 

X-10 Employment

As a [redacted] at X-10, the EE worked in the Building [redacted] [redacted] Division. In the 

CATI Report, the EE indicates being exposed to thorium and enriched uranium. The EE said 

coveralls were always worn and lab coats in some labs. The EE also wore a respirator when 

required. The EE listed work duties and locations by year:

[redacted]–[redacted]: Building [redacted], [redacted], [redacted], [redacted] and 

[redacted]
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

72 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

[redacted]–[redacted]: Building [redacted], [redacted]

[redacted]–[redacted]: Building [redacted], [redacted], coated U & Th fuel particles

[redacted]–[redacted]: Building [redacted], [redacted]

In the DOE records, the EE describes the work duties: 

[Redacted] on [redacted], [redacted], and [redacted] of various materials. I felt 

I was exposed to chemicals, metals, and solvents. I was breathing fumes. 

Cleaning solvents.

The DOE records show that the EE was monitored on a quarterly basis for external exposure to 

gamma and beta radiation. The EE does not appear to have been monitored for neutron 

exposure. The EE was not monitored for internal exposures during employment at X-10. 

II.3 EXTERNAL DOSIMETRY RECORDS 

The administrative record for this worker indicates that this EE was monitored on a quarterly 

exchange schedule for the entire employment period at Y-12. Table II-3 presents the external 

dosimetry data provided by DOE for this worker. 

Table II-3. External Dosimetry Data (mrem) at Y-12 for Case #[Redacted]

Quarter/year Shallow Deep Neutron

2/[redacted] 0 0 0

3/[redacted] 22 11 0

4/[redacted] 59 0 0

1/[redacted] 20 0 0

2/[redacted] 23 0 0

3/[redacted] 145 27 0

4/[redacted] 108 4 0

1/[redacted] 74 9 0

2/[redacted] 35 0 0

3/[redacted] 79 0 0

4/[redacted] 103 13 0

1/[redacted] 44 11 0

2/[redacted] 50 50 0

3/[redacted] 65 65 0

Any reading below the LOD/2 value is considered a zero reading. For example, in the last 

quarter of [redacted], the deep dose reading was 4 mrem. Since this is below the LOD/2 value 

of 15 mrem, the reading is considered a zero reading and 4 mrem is subtracted from the recorded 

dose for that year. 

The DOE records show that the EE was monitored on a quarterly exchange schedule for external 

beta and gamma radiation for the entire employment at X-10. All of the dosimeter readings were 

zero. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

73 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

II.3.1 Reconstruction of External Doses for Y-12 Employment 

SC&A thoroughly reviewed the dosimetry records for Case #[redacted] and found that the EE 

was monitored for external photon, beta, and neutron exposures throughout employment. These 

records, along with the Y-12 Occupational External Dose TBD (ORAUT-TKBS-0014-6) and 

OCAS-IG-001 (External Dose Reconstruction Implementation Guideline) were used to 

reconstruct the external doses for this case. The DR includes an assessment of recorded and 

missed photon/beta dose, missed neutron dose, occupational medical dose, and missed dose from 

skin deposition. Table II-4 is a summary of the assigned doses, and Appendices II.A-1 through 

II.A-7 present the IREP input values used to determine the POC.

Table II-4. Assigned External Doses for Case #[Redacted] during Y-12 Employment

Radiation Type Appendix A-1 

Exposure No.

[redacted]

(rem)

Appendix A-2

Exposure No.

[redacted]

(rem)

Appendix A-3

Exposure No.

[redacted]

(rem)

Recorded photon 1–2 0.142 1–2 0.142 1–2 0.142

Recorded shallow 3– 6 0.637 3–6 0.545 3–6 0.637

Missed photon 7–10 0.165 7–10 0.165 7–10 0.165

Missed neutron 11–14 0.224 11–14 0.224 11–14 0.224

Missed dose from skin 

deposition 53–56 0.280 53–56 0.280 53–56 0.280

Occupational medical 49–52 0.026 49–52 1.080 49–52 0.108

Total 1.474 2.436 1.556

Radiation Type

Appendix 

A-4

Exposure 

No.

[redacted]

(rem)

Appendix 

A-5 

Exposure 

No.

[redacted]

(rem)

Appendix 

A-6

Exposure 

No.

[redacted]

(rem)

Appendix 

A-7

Exposure 

No.

[redacted]

(rem)

Recorded photon 1–2 0.142 1–2 0.142 1–2 0.142 1–2 0.142

Recorded shallow 3–6 0.545 3–6 0.637 3– 6 0.637 3–6 0.637

Missed photon 7–10 0.165 7–10 0.165 7–10 0.165 7–10 0.165

Missed neutron 11– 14 0.224 11–14 0.224 11–14 0.224 11–14 0.224

Missed dose from 

skin deposition 53–56 0.280 53–56 0.280 53–56 0.280 53–56 0.280

Occupational 

medical 49–52 1.080 49–52 0.108 49–52 0.026 49–52 0.108

Total 2.436 1.556 1.474 1.556

DR–Method B used the guidance in ORAUT-OTIB-0017 to assess doses to the skin. A DCF of 

1 is assumed for all skin cancers. Table 6-5 of ORAUT-TKBS-0014-6 recommends the 

following energy ranges of 100% 30–250 keV photons for deep dose, 100% >15 keV electrons 

for shallow dose, and 100% 0.1–2 MeV for neutron dose for Building [redacted].

Recorded Photon Dose 

The EE was monitored on a quarterly basis for external exposure to photons with TLDs. The EE 

did have some dosimeter readings above the LOD. An example of SC&A’s Method B 

calculations is given below for the year [redacted].

For [redacted], the EE had a photon reading of 0.027 rem:

Calculated recorded 30–250 keV photon dose to the skin = 0.027 * 1 = 0.027 rem 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

74 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

SC&A calculated 0.142 rem recorded photon dose to the skin, as cited in entries #1–#2 of each 

appendix. These values are entered as the mean of a normal distribution with a standard 

deviation of 30%. 

Recorded Shallow Dose 

The shallow doses listed in the Y-12 dosimetry records represent the doses captured in the open 

window and, therefore, include both penetrating and non-penetrating dose. The dose from 

electron exposure is determined by subtracting the deep dose from the recorded shallow dose.

Six of the eight skin cancers are located on exposed skin. Beta radiation is attenuated by 

clothing, so skin that is covered would receive a smaller shallow dose. Two of the skin cancers 

are located in areas that would be covered by clothing. The guidance on pages 6 and 7 of 

ORAUT-OTIB-0017 described the method to attenuate shallow dose to skin covered by clothing 

and lab coats. 

All measured and missed non-penetrating doses that are considered electrons 

should be corrected to account for attenuation by clothing or personal protection 

equipment (PPE), if applicable. No attenuation should generally be assumed if 

the skin cancer was diagnosed in an area not normally covered by clothing, such 

as the face. Information on beta attenuation factors for uranium can be found in 

the DOE Standard “Guide of Good Practices for Occupational Radiological 

Protection in Uranium Facilities,” DOE-STD-1136-2000 [DOE 2000] (which is 

based on the DOE Health Physics Manual of Good Practices for Uranium 

Facilities, EGG-2530 [DOE 1988]). Examples from this document of 

transmission factors for uranium through various types of protective clothing 

include: 

• Lab coat (65% Dacron/35% cotton) – 0.91 

• Two pairs of coveralls plus paper liner – 0.80

• Two pairs of gloves plus liner – 0.60 

• Face shield – 0.41 

For likely non-compensable cases, an acceptable claimant-favorable approach is 

to assume 100% transmission (i.e., ignore attenuation). For likely compensable 

cases, an acceptable minimizing approach is to assume a transmission of 0.6 

(unless there is evidence a face shield was used and the skin cancer was on the 

face, in which case 0.41 would be appropriate). For cases in which a best 

estimate is applied and the specific type of protective clothing is unknown, a 

factor of 0.855 for uranium is appropriate (equal to the average of the 0.80 and 

0.91 factors listed above). Note that the transmission factors listed are claimant 

favorable for areas where undergarments (such as a shirt) are worn, because the 

factors are relevant only to the protective clothing material itself. 

We used the best-estimate attenuation factor of 0.855 and applied it to the recorded shallow dose. 

An example of SC&A’s DR-Method B calculations is given below for the year [redacted].
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

75 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

For [redacted], the EE had a shallow dose reading of 0.265 rem.

Calculated recorded shallow dose to the exposed skin = 0.265 * 1 = 0.265 rem 

Calculated recorded shallow dose to the covered skin = 0.265 * 1 * 0.855 = 0.227 rem 

This value is entered as the mean of a normal distribution with a standard deviation of 30%. 

Missed Photon Dose 

Method B assigned missed dose to the skin by multiplying the number of zero readings per year 

by one-half the LOD. External dosimetry data were reviewed in detail. Each quarterly reading 

that is below the LOD/2 is considered a zero reading. The guidance in the attachments to 

ORAUT-OTIB-0017 is used to assess the missed photon dose and missed shallow dose. These 

procedures are specific for the Savannah River Site, Hanford, and the Gaseous Diffusion Plants, 

and have been applied here. 

For any badge cycle with a zero result in either the OW or S reading, or both, 

assign a single missed dose as explained in Items 7-9 below. 

If only the OW reading was reported as zero, the missed dose assigned should be 

the appropriate OW LOD for that era (divided by 2, treated as lognormal) and 

considered electrons (corrected for attenuation, if applicable) or low-energy 

photons (multiplied by 0.6 in the film badge era, if applicable) consistent with the 

approach taken in Step 2. 

If only the S reading was reported as zero, the missed dose assigned should be the 

appropriate S LOD for that era (divided by 2, treated as lognormal) and 

considered 30–250 keV photons. 

If both the OW and S readings were reported as zero, the missed dose assigned 

should be the appropriate OW LOD for that era (divided by 2, treated as 

lognormal) and considered 30–250 keV photons. 

During the film-badge era, for a person potentially exposed to neutrons, assign 

unmonitored neutron dose based on neutron-gamma ratios per the TBD (using an 

organ DCF of 1). 

During the TLD era, for a person potentially exposed to neutrons, if a zero 

neutron result was recorded, assign missed dose per the TBD (using an organ 

DCF of 1). 

The LOD of 30 mrem is used for both deep and shallow dose. The EE had positive shallow dose 

readings (i.e., above the LOD/2 values) for all exchange periods. Therefore, only missed 30–

250 keV photon dose was assigned for this case. An example of SC&A’s Method B missed 

photon dose is given for the year [redacted]. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

76 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Calculated missed photon dose to the skin = # of zero readings * 1⁄2 LOD * DCF 

 = 3 * 0.015 * 1 = 0.045 rem 

DR–Method B calculated a total missed photon dose of 0.165 rem to the skin, as cited in entries 

#7–#10 of each appendix. As per guidance in OCAS-IG-001, these values were entered into the 

IREP program as the geometric mean (GM) of a lognormal distribution with a GSD of 1.52. 

Missed Neutron Dose 

The EE did have zero neutron readings during employment; therefore, SC&A’s Method B

decided it would be appropriate and claimant favorable to assign missed neutron dose. The 

guidance in the TBD recommends using neutron-to-photon dose ratios from Table 6-13, along 

with the number of zero readings, ICRP correction factors, and organ DCFs. The neutron-tophoton dose ratio of 0.7103 is identified as the default value for Y-12. Table 6-11 of the Y-12 

TBD cites the claimant-favorable neutron energy range of 0.1–2 MeV for Building [redacted].

An example of DR–Method B’s missed dose calculation is provided below for [redacted]. 

For [redacted], there are [redacted] zero readings for neutrons:

Missed neutron dose = # of zeroes * LOD/2 * n-g ratio * ICRP CF * DCF 

0.1–2 MeV neutron dose = 3 zeros * 0.015 rem * 0.7103 * 1.91 * 1 = 0.061 rem 

SC&A’s Method B calculated a total of 0.224 rem to the skin for missed neutron dose, as cited in 

entries #11–#14 of each appendix. These values are entered as a lognormal distribution with a 

GSD of 1.52. 

Skin Exposures Associated Deposition of Uranium Directly on Skin and Clothing 

A skin exposure scenario that is of concern at Y-12 is the direct deposition of airborne uranium 

dust on bare skin and clothing. This exposure scenario is not addressed in the Y-12 site profile, 

but was discussed in the 1994 document, Technical Basis for Beta Skin Dose Calculations at the 

Y-12 Plant (Thomas and Bogard 1994), and was raised as a generic issue at the May 21 and July 

18, 2013, meetings of the Dose Reconstruction Subcommittee. At the May 21 meeting, NIOSH 

introduced a strategy for reconstructing skin doses from this scenario for the Bridgeport Brass 

facility, as follows (ABRWH 2013): 

An assessment was made to determine the skin dose from routine skin 

contamination associated with uranium operations. Based on the Technical Basis 

Document: An Exposure Matrix for Bridgeport Brass: Havens Laboratory and 

Adrian Plant (ORAUT-TKBS-0030 Rev. 01), the geometric mean of the Table 3-5 

individual daily weighted-average air concentration is 250 dpm/m3 with a 

geometric standard deviation of 2.2. This results in a 95th percentile air 

concentration of 915 dpm/m3. Assuming a terminal settling velocity of 

0.00075 m/s and 8 hours of operations, a constant air concentration of 

915 dpm/m3 would result in a surface contamination level of 1.98 dpm/cm2. One 

could assume that the skin of the head, neck, and hands were re-contaminated at 

the same level of general surfaces every workday (250 workdays) of the year. The 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

77 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

skin on the head, neck, and hands represent about 14% of the total body skin 

area. A maximizing skin dose rate of 40 mrem per 10,000 dpm/cm2per hour can 

be applied to determine the skin dose to the affected area (Technical Basis for 

Beta Skin Dose Calculations at the Y12 Plant, SRDB 19821) [Thomas and Bogard 

1994]. This would result in a dose to the affected skin of about 16 mrem. Per 

guidance in Interpretation of Dosimetry Data For Assignment of Shallow Dose 

(ORAUT-OTIB-0017 Rev. 01), the 16 mrem to the affected skin could be 

converted to the dose to the skin based on the described approach for nonuniform exposures, resulting in a geometric mean annual skin dose of about 2 

mrem with a geometric standard deviation of 8. As a note, this is a bounding 

estimate using a maximizing skin dose rate and contamination levels. A more 

realistic skin dose rate and the use of the geometric mean air concentration would 

result in an exposure of less than 1 mrem. 

Method B agrees with the basic strategy described by NIOSH, except that substantial skin 

exposure to beta emitters associated with uranium can also contribute significant exposure 

through clothing. NIOSH’s assumption that only bare skin (representing 14% of total skin in the 

above example) is subject to contamination/radiation exposure from the deposition of airborne 

activity is unrealistic. This is particularly true for work environments involving heavy physical 

activity, worker perspiration, and damp clothing. Thus, any deposition of airborne contaminants 

on clothing worn by a worker (as well as clothing coming in contact with existing contaminated 

surfaces in the workplace) must reasonably be assumed to become contaminated, and that, at a 

minimum, the level of contamination is comparable to that of bare skin. 

The Type S uranium intake calculated from the bioassay data was used to derive the uranium 

dust loading at Y-12. The bioassay data and the calculated intakes are described further in 

Section II.4. The Type S uranium intake of 4,854 dpm/day was the largest intake calculated 

from the bioassay data, which translates to a uranium dust loading of 4,045 dpm/m3. This 

uranium dust loading value can be compared to uranium air monitoring data taken at Y-12 in 

1966. The report, Y-12 Plant Quarterly Health Physics Report – Second Quarter CT 1966 (UCC 

1966) states the following: 

Operational type air samples designed to detect levels at specific operations 

indicate eleven locations that exceed an average of 200 d/m/m3. These operations 

located at the Metal Preparation Division are repetitive, short term operations 

that are performed under special Health Physics safety precautions, thus 

minimizing the personnel exposure potential. 

SC&A’s Method B was not able to locate specific air monitoring data for Building [redacted]

during [redacted]–[redacted], but the 1966 Health Physics report does indicate that the average

uranium dust did not exceed an average of 200 dpm/m3 for most operations and locations. It is 

possible that the EE was involved in the metal preparation operations, but the uranium dust 

loading of 4,045 dpm/m3

calculated from the bioassay data represents a claimant-favorable 

assumption of the dust loading.
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

78 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

The annual skin dose associated with the direct deposition of airborne uranium onto skin and 

clothing is estimated as follows: 

 Uranium dust loading for this EE = (4,854 dpm/day)/(1.2 m3

per day inhaled) 

 = 4,045 dpm/m3

Daily Skin Contamination = (4,045dpm/m3)(0.00075 m/s)(3600 sec/hr)(8 hr/day) 

 = 87,372 dpm/m2after 8 hours of exposure 

Unit Conversion = (87,372 dpm/m2

)(m2/10,000 cm2) = 8.7372 dpm/cm2 

Skin Dose Rate = (8.7372 dpm/cm2)(40 mrem/hr cm2/10,000 dpm)1 = 0.0349 mrem/hr 

Yearly Skin Dose = (0.0349 mrem/hr)(8 h/d)(250 d/yr) = 69.9 mrem/yr 

The dose of 69.9 mrem is assigned as >15 keV electrons for each year of employment at Y-12, as 

cited in entries #53–#56 of the appendices. This annual exposure rate is directly proportional to 

the assumed average uranium concentration in urine. It is also important to acknowledge that 

this model assumes all the uranium deposited on skin and clothing during the course of a work 

day is completely removed at the end of the day after showering, and any uranium on the EE’s

clothing is removed during daily laundering. 

Occupational Medical Dose 

Table 3-1 of the Y-12 Occupational Medical Dose TBD (ORAUT-TKBS-0014-3) indicates that 

all employees received annual PA chest x-rays as part of their employment through 1988. 

Although the EE did not have any records of x-rays, DR–Method B assumed the EE had an 

annual PA chest X-ray for each year of employment at Y-12. Table A-3 of ORAUT-TKBS0014-3 lists the entrance skin dose (ENSD) from PA chest x-rays taken through 1969 to be 

0.27 rem. Table A-1 of ORAUT-OTIB-0006 (Dose Reconstruction from Medical X-ray 

Procedures) provides recommendations of how to assign occupational medical dose to the skin 

based on the location of the cancer. They are described as “Skin dose guidance for chest 

projections for the poor collimation period through 1970.” Table II-5 lists each cancer and the 

target organ dose assigned for each location. 

 

1

 SC&A independently checked this DCF and confirmed that it is reasonable. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

79 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table II-5. Dose Assignments to the Skin for X-ray Exams Taken at Y-12 

Skin Cancer Body location from Table A-1 of

OTIB-0006

Recommended 

target organ from 

Table A-1 of 

OTIB-0006

Associated 

exam dose in 

rem ([redacted]) 

from Table A-3 

of ORAUTTKBS-0014-3

[redacted] SCC [redacted] [redacted] [redacted] 0.0064

[redacted] SCC [redacted] [redacted] [redacted] 0.27

[redacted] BCC [redacted] [redacted] [redacted] 0.027

[redacted] BCC [redacted] [redacted] [redacted] 0.027

[redacted] BCC [redacted] [redacted] [redacted] 0.27

[redacted] SCC [redacted] [redacted] [redacted] 0.0064

[redacted] SCC [redacted] [redacted] [redacted] 0.0064

[redacted] SCC [redacted] [redacted] [redacted] 0.027

These values were entered into IREP as acute 30–250 keV photons with a normal distribution 

and a standard deviation of 30%. 

II.3.2 Reconstruction of External Dose for X-10 Employment 

Method B’s review of the X-10 dosimetry records for Case #[redact] found that this EE was 

monitored for external photon and beta exposures throughout employment. These records, along 

with the X-10 Occupational External Dose TBD (ORAUT-TKBS-0012-6) and OCAS-IG-001, 

were used to reconstruct the external doses for this case. The DR includes an assessment of 

missed photon/beta dose and occupational medical dose. The DOE records show that the EE 

was monitored mostly on a quarterly basis from [redact] through [redact], and did not have any 

dosimeter readings above the LOD/2. Therefore, only missed dose is assigned for this time 

period. The EE did not appear to be monitored for neutron exposure and, according to 

Section 6.3.4.2.2 of ORAUT-TKBS-0012-6, the EE was not at risk for exposure to neutron 

radiation. Table II-6 is a summary of the assigned doses, and Appendices II.A-1 through II.A-7 

present the IREP input values used to determine the POC. 

Table II-6. Assigned External Doses for Case #[Redacted] during X-10 Employment

Radiation Type

Appendix 

II.A-1 

Exposure 

No.

[redacted]

(rem)

Appendix 

II.A-2

Exposure 

No.

[redacted]

(rem)

Appendix 

II.A-3

Exposure 

No.

[redacted]

(rem)

Appendix 

II.A-4

Exposure 

No.

[redacted]

(rem)

Missed photon 15–48 0.920 15–48 0.920 15–48 0.920 15–48 0.920

Occupational medical 168–201 0.148 183–216 0.433 189–222 0.433 189–222 4.354

Total 1.068 1.353 1.353 5.274

Radiation Type Appendix II.A-5 

Exposure No.

[redacted]

(rem)

Appendix II.A-6

Exposure No.

[redacted]

(rem)

Appendix II.A-7

Exposure No.

[redacted]

(rem)

Missed photon 15–48 0.920 15–48 0.920 15–48 0.920

Occupational medical 192–225 0.148 192–225 0.148 195–228 0.433

Total 1.068 1.068 1.353
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

80 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Missed Photon Dose 

Table 6-24 of ORAUT-TKBS-0012-6 indicates that X-10 workers were usually monitored on a 

quarterly basis from 1956 to the present. Table 6-24 also lists the LOD for the X-10 beta/photon 

dosimeters. For the years 1956–1974, the LOD was 0.030 rem, and for the years 1975 to the 

present, the LOD was 0.010 rem. For this case, some of the dosimetry records prior to [redact] 

are difficult to read. In addition, the external dose readings for [redact] to [redact] are presented 

as a yearly summary. DR–Method B decided to assume a quarterly dosimeter exchange for each 

year of employment at X-10. All of the recorded values are zero readings; therefore, only missed 

photon dose is assigned. An example of Method B’s missed photon dose is given for the year 

[redact]. 

Calculated missed photon dose to the skin = # of zero readings * 1⁄2 LOD * DCF 

 = 4 * 0.015 * 1 = 0.060 rem 

Method B calculated 0.92 rem missed photon dose to the skin, as cited in entries #15–#48 in 

each of the appendices. As per the procedures in OCAS-IG-001, these values were entered into 

the IREP program as the GM of a lognormal distribution with a GDS of 1.52.

Occupational Medical Dose 

The EE did not have any x-ray records in the case file, but the EE did state in the CATI Report 

receiving annual x-rays during employment at X-10. DR–Method B assigned occupational 

medical dose for each year of employment using the values in Table 3-6 of ORAUT-TKBS0012-3 and the recommendations in Table A-1 of ORAUT-OTIB-0006. Table II-7 lists the 

assigned target organ and dose for each skin cancer. 

Table II-7. Dose Assignments to the Skin for X-ray Exams taken at X-10

Skin Cancer

Body location 

from Table A-1 

of OTIB-0006

Recommended 

target organ from 

Table A-1 of OTIB0006

([redacted]–

[redacted])

Associated 

exam dose in 

rem from 

Table 3-6 of 

ORAUTTKBS-0012-3

Recommended 

target organ from 

Table A-1 of 

OTIB-0006 

([redacted]–

[redacted])

Associated exam 

dose in rem from 

Table 3-6 of 

ORAUT-TKBS0012-3

[redacted] SCC [redacted] [redacted] [redacted] 5.98e-3 [redacted] 1.36e-3

[redacted] SCC [redacted] [redacted] [redacted] 0.0181 [redacted] 0.0031

[redacted] BCC [redacted] [redacted] [redacted] 0.0181 [redacted] 0.0031

[redacted] BCC [redacted] [redacted] [redacted] 0.0181 [redacted] 0.0031

[redacted] BCC [redacted] [redacted] [redacted] 0.181 [redacted] 0.031

[redacted] SCC [redacted] [redacted] [redacted] 5.98e-3 [redacted] 1.36e-3

[redacted] SCC [redacted] [redacted] [redacted] 5.98e-3 [redacted] 1.36e-3

[redacted] SCC [redacted] [redacted] [redacted] 0.0181 [redacted] 0.0031

These values were entered into IREP as acute 30–250 keV photons with a normal distribution 

and a standard deviation of 30%. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

81 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

II.4 INTERNAL DOSIMETRY RECORDS 

The EE was only monitored for internal exposure during employment at Y-12. Monitoring for 

uranium was conducted by means of quarterly urinalysis bioassays and yearly lung counts. The 

EE’s internal monitoring results are summarized in Tables II.8 and II.9 below. 

Table II-8. Uranium Bioassay Results (gross alpha) for Case #[Redacted]

Year Quarter dpm/d

[redacted] 1 No data

2 No data

3 8

4 13

[redacted] 1 18

2 13

3 40

4 18

[redacted] 1 10

2 11

3 5

4 5

[redacted] 1 7

2 39

3 36

4 No data

Table II-9. Lung Count Measurements for Case #[Redacted]

Date Radionuclide Result

[redacted] Thorium 0 mg

U-235 25 μg

[redacted] Thorium 0 mg

U-235 -14 μg

[redacted] Thorium 0 mg

U-235 40 μg

The DOE records did not contain any internal monitoring records for this EE during employment 

at X-10. 

II.4.1 Reconstruction of Internal Dose at Y-12 

SC&A performed the internal dose assessment for this case using the urinalysis bioassay data 

and the lung count data and compared the results. Since the EE was monitored for U-235 with 

lung counts, the EE most likely worked with 93% highly enriched uranium. Section 5.4.2.1 of 

ORAUT-TKBS-0014-5 describes the following regarding internal dose monitoring: 

Individuals working in NU or DU areas had results reported as 238U, and workers 

in enriched areas had results reported as 235U. Assumptions that are favorable to 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

82 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

claimants should be based on conversions of 93% enrichment for 235U (oralloy 

VHEU) and natural isotopic abundances for 238U.

Urinalysis Bioassays for Uranium 

The EE was monitored for internal exposure to uranium by quarterly urinalysis bioassays, which 

measured gross alpha radiation in units of dpm/day. Table A-1 of ORAUT-TKBS-0014-5 lists 

the gross alpha minimum detectable level (MDL) for bioassays as 26 dpm/day. Several of the 

bioassay readings were slightly above the MDL. The guidance in ORAUT-OTIB-0060, Internal 

Dose Reconstruction, recommends a chronic intake assumption for positive values that are 

within a factor of 2 of the MDL. Since all of the positive bioassay readings were within that 

range, we assigned the calculated intake as a chronic exposure. Table II-9 lists SC&A’s DR–

Method B assumptions regarding the bioassay analysis. Any measured values that were less than

1⁄2 MDL are assumed to be at the 1⁄2 MDL value of 13 dpm/day. The exact dates of the quarterly 

measurements are not known, so we assigned the measurement date as the last calendar day of 

the quarter. All intakes are assumed to be U-234, since the DCFs for U-234, U-235, and U-238 

are nearly identical, except the DCF for U-234 is slightly higher than those for the other isotopes. 

Hence, to simplify the analysis in a slightly claimant-favorable manner, U-234 is used as a 

surrogate for the intake of U-235 and U-238. 

Table II-10. Urinalysis Bioassay Analysis 

Year Quarter Assumed 

measurement date

Gross alpha 

(dpm/d)

IMBA input

value (dpm/d)

IMBA 

input type

[redacted] 1 No data No data No data No data

2 No data No data No data No data

3 [redacted] 8 13 Real

4 [redacted] 13 13 Real

[redacted] 1 [redacted] 18 18 Real

2 [redacted] 13 13 Real

3 [redacted] 40 40 Real

4 [redacted] 18 18 Real

[redacted] 1 [redacted] 10 13 Real

2 [redacted] 11 13 Real

3 [redacted] 5 13 Real

4 [redacted] 5 13 Real

[redacted] 1 [redacted] 7 13 Real

2 [redacted] 39 39 Real

3 [redacted] 36 36 Real

4 No data No data No data No data

Chronic intakes and annual doses were calculated for absorption Types F, M, and S and are listed 

in Table II-10. The Type S intakes and doses were found to be the largest, and they were used in 

the IREP calculation for determining the POC. The total assigned dose to the skin from internal 

exposure to uranium ranged from 0.065 to 0.075 rem, depending on the date of diagnosis. In 

order to simplify the IMBA calculations, the annual internal doses were calculated for the skin 

cancer diagnosed in [redact]. For the other seven cancers, the [redact] dose was assumed to be 

the annual internal dose through the date of diagnosis. For example, the [redact] dose is 

calculated as 1.17E-3 rem. For the cancer diagnosed in [redact], that value is assumed for the 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

83 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

years [redact] through [redact]. This simplification results in a slight overestimate of the 

internal dose.

Table II-11. Calculated Uranium Intakes and Doses using Bioassay Data 

U-234 Absorption Type Intake dpm/day

Type S 4854

Type M 227.6

Type F 53.3

Lung Counts for Uranium 

SC&A also performed internal dose analysis using the EE’s uranium lung count data. All of the 

lung count measurements are below the MDLs. Table 5-11 of the Y-12 TBD ORAUT-TKBS0014-5 recommends using the claimant-favorable MDL of U-235 as 130 g. As a means of 

comparison, we performed an internal dose assessment using the U-235 lung count 

measurements, assuming exposures to both U-235 and U-234. The annual doses to the skin for 

Type M and Type S U-235 intakes were all less than 1 mrem/year, so they were not considered 

for the DR. The Type F intake and doses are several orders of magnitude larger and were 

considered unrealistically high and are not consistent with the bioassay results. Page 12 of the 

Y-12 TBD also notes the following: 

. . . for the vast majority of individuals, lung clearance took place in approximate 

accordance with the ICRP Publication 2 (ICRP 1959) insoluble model, which fits 

within the current type M framework. . . .

Therefore, SC&A determined that the internal doses calculated from the bioassay data are both 

claimant favorable and scientifically sound for this case. 

II.4.2 Reconstruction of Internal Dose at X-10 

The EE was monitored for internal exposures during employment at X-10. Method B decided to 

assign internal dose using the ORNL internal coworker model presented in ORAUT-OTIB-0034. 

This model includes intakes from Sr-90, Ru-106, Cs-137, Ce-144, U-234, Pu-239, and Am-241, 

which represent recommended 50th percentile values as presented below in Table II-11. The 

IMBA program was used to calculate the doses to the skin from these intakes for absorption 

types listed in Table II-11, assuming a chronic intake throughout the duration of employment 

([redact]–[redact]).
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

84 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Table II-12. X-10 Internal Dose Coworker Intakes 

Radionuclide Absorption 

Type Year Intake (dpm/d)

Sr-90 Type F

Type S

Type S

All

[redacted]–[redacted]

[redacted]–[redacted]

15.52

795

425.5

Ru-106 Type F All 103.8

Cs-137 Type F All 34.1

Ce-144 Type F All 170.5

U-234 Type F

Type F

Type M

Type M

Thru [redacted]

[redacted]–[redacted]

Thru [redacted]

[redacted]–[redacted]

0.413

0.0957

1.641

0.294

Pu-239 Type M [redacted]–[redacted]

[redacted]–[redacted]

7.35

1.614

Am-241 Type M [redacted]–[redacted]

[redacted]–[redacted]

6.673

2.207

The annual skin dose results for Sr-90, Ru-106, Cs-137, and U-234 were all less than 1 mrem per 

year and therefore were not included in the IREP POC calculation. Most of the annual skin 

doses from exposure to Pu-239, Am-241, and Ce-144 were above 1 mrem per year and were 

included in our DR. In order to simplify the IMBA calculations, the annual internal doses were 

calculated for the skin cancers diagnosed in [redact] and [redact]. For the other six cancers, the 

[redact] dose was assumed to be the annual internal dose through the date of diagnosis. Since 

the annual internal doses after [redact] are less than 1 mrem/year, this does not have a 

significant effect on the total dose assignment. 

II.5 Calculation of POC 

The IREP input values of Appendices II.A-1 through II.A-7 were imported into the IREP 

program available on the NIOSH Division of Compensation Analysis and Support (DCAS) web 

site. Since there are multiple primary cancer sites for this case, the multiple cancer site portion 

of the IREP program was used in order to determine the total POC for this DR. Table II-12 

presents the calculated POC for each skin cancer site. 

Table II-13. Calculated POC for Skin Cancers for Case #[Redacted]

Skin cancer POC

[redacted] SCC [redacted] 1.21

[redacted] SCC [redacted] 1.70

[redacted] BCC [redacted] 11.86

[redacted] BCC [redacted] 11.86

[redacted] BCC [redacted] 26.27

[redacted] SCC [redacted] 11.35

[redacted] SCC [redacted] 1.16

[redacted] SCC [redacted] 1.43
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

85 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

A hand calculation for the POC from the multiple cancers is as follows: 

(1 – POC1) * (1 – POC2) * (1 – POC3) * (1 – POC4) * (1 – POC5 ) * (1 – POC6 ) * 

(1 – POC7) * (1 – POC8) = 1 – POCtotal

Therefore, for this case: 

(1 – POCtotal) = 0.48 

1 – 0.48 = 0.52

POCtotal = 52% 

The POC is determined to be 52%, which would make this claim eligible for compensation. 

II.6 REFERENCES 

ABRWH. 2013. Transcript from Meeting of the Advisory Board's Subcommittee on Dose 

Reconstruction Reviews, available at the NIOSH website: 

http://www.cdc.gov/niosh/ocas/pubm2013.html#may, May 21, 2013. 

DOE 1988. Health Physics Manual of Good Practices for Uranium Facilities, EGG-2530, U.S. 

Department of Energy, Washington, DC. June 1988. 

DOE 2000. Guide of Good Practices for Occupational Radiological Protection in Uranium 

Facilities, DOE-STD-1136-2000, U.S. Department of Energy, Washington, DC. August 2000. 

ICRP 1959. Permissible Dose for Internal Radiation, ICRP Publication 2. International 

Commission on Radiation Protection. Pergamon Press. 1959. 

OCAS-IG-001. 2007. External Dose Reconstruction Implementation Guideline, Rev. 3, 

National Institute for Occupational Safety and Health, Office of Compensation Analysis and 

Support, Cincinnati, Ohio. November 21, 2007. 

ORAUT-OTIB-0006. 2011. Dose Reconstruction from Occupationally Medical X-ray 

Procedures, Rev. 04, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 20, 

2011.

ORAUT-OTIB-0017. 2005. Technical Information Bulletin: Interpretation of Dosimetry Data 

for Assignment of Shallow Dose, Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, 

Ohio. October 11, 2005. 

ORAUT-OTIB-0034. 2011. Technical Information Bulletin: Internal Dosimetry Coworker 

Data for X-10, Rev. 01, Oak Ridge Associated Universities, Cincinnati, Ohio. April 23, 2013. 

ORAUT-OTIB-0060. 2007. Internal Dose Reconstruction, Rev. 00, Oak Ridge Associated 

Universities Team, Cincinnati, Ohio. February 6, 2007. 
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

86 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

ORAUT-TKBS-0012-3. 2007. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational Medical Dose, Rev. 02, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. October 1, 2007.

ORAUT-TKBS-0012-6. 2007. Technical Basis Document for the Oak Ridge National 

Laboratory – Occupational External Dose, Rev. 01, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. September 10, 2007. 

ORAUT-TKBS-0014-3. 2007. Y-12 National Security Complex – Occupational Medical Dose,

Rev. 01, Oak Ridge Associated Universities Team, Cincinnati, Ohio. June 18, 2007. 

ORAUT-TKBS-0014-5. 2012. Y-12 National Security Complex – Occupational Internal Dose, 

Rev. 03, Oak Ridge Associated Universities Team, Cincinnati, Ohio. March 12, 2012.

ORAUT-TKBS-0014-6. 2009. Y-12 National Security Complex – Occupational External Dose, 

Rev. 02, Oak Ridge Associated Universities Team, Cincinnati, Ohio. December 18, 2009. 

ORAUT-TKBS-0030. 2013. Technical Basis Document: An Exposure Matrix for Bridgeport 

Brass: Havens Laboratory and Adrian Plant, Rev. 01, Oak Ridge Associated Universities Team, 

Cincinnati, Ohio. August 9, 2013. 

Thomas, J.M., and R.S. Bogard, 1994. Technical Basis for Beta Skin Dose Calculations at the 

Y-12 Plant, Oak Ridge Y-12 Plant, Oak Ridge, Tennessee. March 1994. (SRDB 19821) 

UCC 1966. Y-12 Plant Quarterly Health Physics Report – Second Quarter CT 1966, Report 

Number Y-KB-73, Union Carbide Corporation Nuclear Division, Y-12 Radiation Safety 

Department, Oak Ridge, Tennessee. August 10, 1966. (SRDB 082902)
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

87 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-1: IREP INPUT – [REDACTED] SCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 

1

Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.070 0.021

4 [redacted] acute electrons E>15keV normal 0.265 0.080

5 [redacted] acute electrons E>15keV normal 0.269 0.081

6 [redacted] acute electrons E>15keV normal 0.033 0.010

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

50 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

51 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

52 [redacted] acute photons E=30-250keV Normal 0.0064 0.00192

53 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

88 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-1: IREP Input – [Redacted] SCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha Lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha Lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha Lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha Lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha Lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha Lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha Lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha Lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha Lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha Lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha Lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha Lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha Lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha Lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

83 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha Lognormal 1.17E-03 3.00E+00

96 [redacted] chronic alpha Lognormal 7.88E-06 3.00E+00

97 [redacted] chronic alpha Lognormal 1.96E-04 3.00E+00

98 [redacted] chronic alpha Lognormal 4.65E-04 3.00E+00

99 [redacted] chronic alpha Lognormal 7.08E-04 3.00E+00

100 [redacted] chronic alpha Lognormal 9.18E-04 3.00E+00

101 [redacted] chronic alpha Lognormal 1.11E-03 3.00E+00

102 [redacted] chronic alpha Lognormal 1.29E-03 3.00E+00

103 [redacted] chronic alpha Lognormal 1.45E-03 3.00E+00

104 [redacted] chronic alpha Lognormal 1.61E-03 3.00E+00

105 [redacted] chronic alpha Lognormal 1.76E-03 3.00E+00

106 [redacted] chronic alpha Lognormal 1.91E-03 3.00E+00

107 [redacted] chronic alpha Lognormal 2.06E-03 3.00E+00

108 [redacted] chronic alpha Lognormal 2.20E-03 3.00E+00

109 [redacted] chronic alpha Lognormal 2.34E-03 3.00E+00

110 [redacted] chronic alpha Lognormal 2.48E-03 3.00E+00

111 [redacted] chronic alpha Lognormal 2.63E-03 3.00E+00
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

89 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-1: IREP Input – [Redacted] SCC [Redacted] (continued)

112 [redacted] chronic alpha Lognormal 2.67E-03 3.00E+00

113 [redacted] chronic alpha Lognormal 2.60E-03 3.00E+00

114 [redacted] chronic alpha Lognormal 2.55E-03 3.00E+00

115 [redacted] chronic alpha Lognormal 2.50E-03 3.00E+00

116 [redacted] chronic alpha Lognormal 2.42E-03 3.00E+00

117 [redacted] chronic alpha Lognormal 2.37E-03 3.00E+00

118 [redacted] chronic alpha Lognormal 2.34E-03 3.00E+00

119 [redacted] chronic alpha Lognormal 2.32E-03 3.00E+00

120 [redacted] chronic alpha Lognormal 2.30E-03 3.00E+00

121 [redacted] chronic alpha Lognormal 2.30E-03 3.00E+00

122 [redacted] chronic alpha Lognormal 2.30E-03 3.00E+00

123 [redacted] chronic alpha Lognormal 2.31E-03 3.00E+00

124 [redacted] chronic alpha Lognormal 2.30E-03 3.00E+00

125 [redacted] chronic alpha Lognormal 2.31E-03 3.00E+00

126 [redacted] chronic alpha Lognormal 2.32E-03 3.00E+00

127 [redacted] chronic alpha Lognormal 2.33E-03 3.00E+00

128 [redacted] chronic alpha Lognormal 2.33E-03 3.00E+00

129 [redacted] chronic alpha Lognormal 2.34E-03 3.00E+00

130 [redacted] chronic alpha Lognormal 2.35E-03 3.00E+00

131 [redacted] chronic alpha Lognormal 1.53E-03 3.00E+00

132 [redacted] chronic alpha Lognormal 3.47E-06 3.00E+00

133 [redacted] chronic alpha Lognormal 6.82E-05 3.00E+00

134 [redacted] chronic alpha Lognormal 1.51E-04 3.00E+00

135 [redacted] chronic alpha Lognormal 2.43E-04 3.00E+00

136 [redacted] chronic alpha Lognormal 3.42E-04 3.00E+00

137 [redacted] chronic alpha Lognormal 4.49E-04 3.00E+00

138 [redacted] chronic alpha Lognormal 5.63E-04 3.00E+00

139 [redacted] chronic alpha Lognormal 6.85E-04 3.00E+00

140 [redacted] chronic alpha Lognormal 8.08E-04 3.00E+00

141 [redacted] chronic alpha Lognormal 9.36E-04 3.00E+00

142 [redacted] chronic alpha Lognormal 1.07E-03 3.00E+00

143 [redacted] chronic alpha Lognormal 1.21E-03 3.00E+00

144 [redacted] chronic alpha Lognormal 1.35E-03 3.00E+00

145 [redacted] chronic alpha Lognormal 1.49E-03 3.00E+00

146 [redacted] chronic alpha Lognormal 1.63E-03 3.00E+00

147 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

148 [redacted] chronic alpha Lognormal 1.90E-03 3.00E+00

149 [redacted] chronic alpha Lognormal 1.99E-03 3.00E+00

150 [redacted] chronic alpha Lognormal 2.08E-03 3.00E+00

151 [redacted] chronic alpha Lognormal 2.16E-03 3.00E+00

152 [redacted] chronic alpha Lognormal 2.22E-03 3.00E+00

153 [redacted] chronic alpha Lognormal 2.27E-03 3.00E+00

154 [redacted] chronic alpha Lognormal 2.32E-03 3.00E+00

155 [redacted] chronic alpha Lognormal 2.37E-03 3.00E+00

156 [redacted] chronic alpha Lognormal 2.40E-03 3.00E+00

157 [redacted] chronic alpha Lognormal 2.43E-03 3.00E+00

158 [redacted] chronic alpha Lognormal 2.46E-03 3.00E+00

159 [redacted] chronic alpha Lognormal 2.50E-03 3.00E+00

160 [redacted] chronic alpha Lognormal 2.52E-03 3.00E+00

161 [redacted] chronic alpha Lognormal 2.55E-03 3.00E+00

162 [redacted] chronic alpha Lognormal 2.57E-03 3.00E+00

163 [redacted] chronic alpha Lognormal 2.60E-03 3.00E+00

164 [redacted] chronic alpha Lognormal 2.61E-03 3.00E+00

165 [redacted] chronic alpha Lognormal 2.63E-03 3.00E+00

166 [redacted] chronic alpha Lognormal 2.64E-03 3.00E+00

167 [redacted] chronic alpha Lognormal 1.72E-03 3.00E+00

168 [redacted] acute photons E=30-250keV Normal 0.006 0.002
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

90 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-1: IREP Input – [Redacted] SCC [Redacted] (continued)

169 [redacted] acute photons E=30-250keV Normal 0.006 0.002

170 [redacted] acute photons E=30-250keV Normal 0.006 0.002

171 [redacted] acute photons E=30-250keV Normal 0.006 0.002

172 [redacted] acute photons E=30-250keV Normal 0.006 0.002

173 [redacted] acute photons E=30-250keV Normal 0.006 0.002

174 [redacted] acute photons E=30-250keV Normal 0.006 0.002

175 [redacted] acute photons E=30-250keV Normal 0.006 0.002

176 [redacted] acute photons E=30-250keV Normal 0.006 0.002

177 [redacted] acute photons E=30-250keV Normal 0.006 0.002

178 [redacted] acute photons E=30-250keV Normal 0.006 0.002

179 [redacted] acute photons E=30-250keV Normal 0.006 0.002

180 [redacted] acute photons E=30-250keV Normal 0.006 0.002

181 [redacted] acute photons E=30-250keV Normal 0.006 0.002

182 [redacted] acute photons E=30-250keV Normal 0.006 0.002

183 [redacted] acute photons E=30-250keV Normal 0.006 0.002

184 [redacted] acute photons E=30-250keV Normal 0.006 0.002

185 [redacted] acute photons E=30-250keV Normal 0.006 0.002

186 [redacted] acute photons E=30-250keV Normal 0.006 0.002

187 [redacted] acute photons E=30-250keV Normal 0.006 0.002

188 [redacted] acute photons E=30-250keV Normal 0.006 0.002

189 [redacted] acute photons E=30-250keV Normal 0.006 0.002

190 [redacted] acute photons E=30-250keV Normal 0.001 0.000

191 [redacted] acute photons E=30-250keV Normal 0.001 0.000

192 [redacted] acute photons E=30-250keV Normal 0.001 0.000

193 [redacted] acute photons E=30-250keV Normal 0.001 0.000

194 [redacted] acute photons E=30-250keV Normal 0.001 0.000

195 [redacted] acute photons E=30-250keV Normal 0.001 0.000

196 [redacted] acute photons E=30-250keV Normal 0.001 0.000

197 [redacted] acute photons E=30-250keV Normal 0.001 0.000

198 [redacted] acute photons E=30-250keV Normal 0.001 0.000

199 [redacted] acute photons E=30-250keV Normal 0.001 0.000

200 [redacted] acute photons E=30-250keV Normal 0.001 0.000

201 [redacted] acute photons E=30-250keV Normal 0.001 0.000

202 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

203 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

204 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000

205 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

206 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

207 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

208 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

209 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

210 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

211 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

212 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

213 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

214 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

215 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

216 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

217 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

218 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

219 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

220 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

221 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

222 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

223 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

224 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

225 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

91 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-1: IREP Input – [Redacted] SCC [Redacted] (continued)

226 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

237 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

92 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-2: IREP INPUT – [REDACTED] SCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.060 0.018

4 [redacted] acute electrons E>15keV normal 0.227 0.068

5 [redacted] acute electrons E>15keV normal 0.230 0.069

6 [redacted] acute electrons E>15keV normal 0.028 0.008

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

93 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] (continued)

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.27 0.081

50 [redacted] acute photons E=30-250keV normal 0.27 0.081

51 [redacted] acute photons E=30-250keV normal 0.27 0.081

52 [redacted] acute photons E=30-250keV Normal 0.27 0.081

53 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

55 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha Lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha Lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha Lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha Lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha Lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha Lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha Lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha Lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha Lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha Lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha Lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha Lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha Lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha Lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

94 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] (continued)

98 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha Lognormal 6.71E-04 3.00E+00

101 [redacted] chronic alpha Lognormal 7.88E-06 3.000

102 [redacted] chronic alpha Lognormal 1.96E-04 3.000

103 [redacted] chronic alpha Lognormal 4.65E-04 3.000

104 [redacted] chronic alpha Lognormal 7.08E-04 3.000

105 [redacted] chronic alpha Lognormal 9.18E-04 3.000

106 [redacted] chronic alpha Lognormal 1.11E-03 3.000

107 [redacted] chronic alpha Lognormal 1.29E-03 3.000

108 [redacted] chronic alpha Lognormal 1.45E-03 3.000

109 [redacted] chronic alpha Lognormal 1.61E-03 3.000

110 [redacted] chronic alpha Lognormal 1.76E-03 3.000

111 [redacted] chronic alpha Lognormal 1.91E-03 3.000

112 [redacted] chronic alpha Lognormal 2.06E-03 3.000

113 [redacted] chronic alpha Lognormal 2.20E-03 3.000

114 [redacted] chronic alpha Lognormal 2.34E-03 3.000

115 [redacted] chronic alpha Lognormal 2.48E-03 3.000

116 [redacted] chronic alpha Lognormal 2.63E-03 3.000

117 [redacted] chronic alpha Lognormal 2.67E-03 3.000

118 [redacted] chronic alpha Lognormal 2.60E-03 3.000

119 [redacted] chronic alpha Lognormal 2.55E-03 3.000

120 [redacted] chronic alpha Lognormal 2.50E-03 3.000

121 [redacted] chronic alpha Lognormal 2.42E-03 3.000

122 [redacted] chronic alpha Lognormal 2.37E-03 3.000

123 [redacted] chronic alpha Lognormal 2.34E-03 3.000

124 [redacted] chronic alpha Lognormal 2.32E-03 3.000

125 [redacted] chronic alpha Lognormal 2.30E-03 3.000

126 [redacted] chronic alpha Lognormal 2.30E-03 3.000

127 [redacted] chronic alpha Lognormal 2.30E-03 3.000

128 [redacted] chronic alpha Lognormal 2.31E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.31E-03 3.000

131 [redacted] chronic alpha Lognormal 2.32E-03 3.000

132 [redacted] chronic alpha Lognormal 2.33E-03 3.000

133 [redacted] chronic alpha Lognormal 2.33E-03 3.000

134 [redacted] chronic alpha Lognormal 2.34E-03 3.000

135 [redacted] chronic alpha Lognormal 2.35E-03 3.000

136 [redacted] chronic alpha Lognormal 2.37E-03 3.000

137 [redacted] chronic alpha Lognormal 2.37E-03 3.000

138 [redacted] chronic alpha Lognormal 2.38E-03 3.000

139 [redacted] chronic alpha Lognormal 2.39E-03 3.000

140 [redacted] chronic alpha Lognormal 2.41E-03 3.000

141 [redacted] chronic alpha Lognormal 9.09E-04 3.000

142 [redacted] chronic alpha Lognormal 3.47E-06 3.000

143 [redacted] chronic alpha Lognormal 6.82E-05 3.000

144 [redacted] chronic alpha Lognormal 1.51E-04 3.000

145 [redacted] chronic alpha Lognormal 2.43E-04 3.000

146 [redacted] chronic alpha Lognormal 3.42E-04 3.000

147 [redacted] chronic alpha Lognormal 4.49E-04 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

95 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] (continued)

148 [redacted] chronic alpha Lognormal 5.63E-04 3.000

149 [redacted] chronic alpha Lognormal 6.85E-04 3.000

150 [redacted] chronic alpha Lognormal 8.08E-04 3.000

151 [redacted] chronic alpha Lognormal 9.36E-04 3.000

152 [redacted] chronic alpha Lognormal 1.07E-03 3.000

153 [redacted] chronic alpha Lognormal 1.21E-03 3.000

154 [redacted] chronic alpha Lognormal 1.35E-03 3.000

155 [redacted] chronic alpha Lognormal 1.49E-03 3.000

156 [redacted] chronic alpha Lognormal 1.63E-03 3.000

157 [redacted] chronic alpha Lognormal 1.78E-03 3.000

158 [redacted] chronic alpha Lognormal 1.90E-03 3.000

159 [redacted] chronic alpha Lognormal 1.99E-03 3.000

160 [redacted] chronic alpha Lognormal 2.08E-03 3.000

161 [redacted] chronic alpha Lognormal 2.16E-03 3.000

162 [redacted] chronic alpha Lognormal 2.22E-03 3.000

163 [redacted] chronic alpha Lognormal 2.27E-03 3.000

164 [redacted] chronic alpha Lognormal 2.32E-03 3.000

165 [redacted] chronic alpha Lognormal 2.37E-03 3.000

166 [redacted] chronic alpha Lognormal 2.40E-03 3.000

167 [redacted] chronic alpha Lognormal 2.43E-03 3.000

168 [redacted] chronic alpha Lognormal 2.46E-03 3.000

169 [redacted] chronic alpha Lognormal 2.50E-03 3.000

170 [redacted] chronic alpha Lognormal 2.52E-03 3.000

171 [redacted] chronic alpha Lognormal 2.55E-03 3.000

172 [redacted] chronic alpha Lognormal 2.57E-03 3.000

173 [redacted] chronic alpha Lognormal 2.60E-03 3.000

174 [redacted] chronic alpha Lognormal 2.61E-03 3.000

175 [redacted] chronic alpha Lognormal 2.63E-03 3.000

176 [redacted] chronic alpha Lognormal 2.64E-03 3.000

177 [redacted] chronic alpha Lognormal 2.67E-03 3.000

178 [redacted] chronic alpha Lognormal 2.67E-03 3.000

179 [redacted] chronic alpha Lognormal 2.69E-03 3.000

180 [redacted] chronic alpha Lognormal 2.70E-03 3.000

181 [redacted] chronic alpha Lognormal 2.72E-03 3.000

182 [redacted] chronic alpha Lognormal 1.03E-03 3.000

183 [redacted] acute photons E=30-250keV Normal 0.018 0.005

184 [redacted] acute photons E=30-250keV Normal 0.018 0.005

185 [redacted] acute photons E=30-250keV Normal 0.018 0.005

186 [redacted] acute photons E=30-250keV Normal 0.018 0.005

187 [redacted] acute photons E=30-250keV Normal 0.018 0.005

188 [redacted] acute photons E=30-250keV Normal 0.018 0.005

189 [redacted] acute photons E=30-250keV Normal 0.018 0.005

190 [redacted] acute photons E=30-250keV Normal 0.018 0.005

191 [redacted] acute photons E=30-250keV Normal 0.018 0.005

192 [redacted] acute photons E=30-250keV Normal 0.018 0.005

193 [redacted] acute photons E=30-250keV Normal 0.018 0.005

194 [redacted] acute photons E=30-250keV Normal 0.018 0.005

195 [redacted] acute photons E=30-250keV Normal 0.018 0.005

196 [redacted] acute photons E=30-250keV Normal 0.018 0.005

197 [redacted] acute photons E=30-250keV Normal 0.018 0.005
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

96 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] (continued)

198 [redacted] acute photons E=30-250keV Normal 0.018 0.005

199 [redacted] acute photons E=30-250keV Normal 0.018 0.005

200 [redacted] acute photons E=30-250keV Normal 0.018 0.005

201 [redacted] acute photons E=30-250keV Normal 0.018 0.005

202 [redacted] acute photons E=30-250keV Normal 0.018 0.005

203 [redacted] acute photons E=30-250keV Normal 0.018 0.005

204 [redacted] acute photons E=30-250keV Normal 0.018 0.005

205 [redacted] acute photons E=30-250keV Normal 0.003 0.001

206 [redacted] acute photons E=30-250keV Normal 0.003 0.001

207 [redacted] acute photons E=30-250keV Normal 0.003 0.001

208 [redacted] acute photons E=30-250keV Normal 0.003 0.001

209 [redacted] acute photons E=30-250keV Normal 0.003 0.001

210 [redacted] acute photons E=30-250keV Normal 0.003 0.001

211 [redacted] acute photons E=30-250keV Normal 0.003 0.001

212 [redacted] acute photons E=30-250keV Normal 0.003 0.001

213 [redacted] acute photons E=30-250keV Normal 0.003 0.001

214 [redacted] acute photons E=30-250keV Normal 0.003 0.001

215 [redacted] acute photons E=30-250keV Normal 0.003 0.001

216 [redacted] acute photons E=30-250keV Normal 0.003 0.001

217 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

218 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

219 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000

220 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

221 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

222 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

223 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

224 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

225 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

226 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

97 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-2: IREP Input – [Redacted] SCC [Redacted] (continued)

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

252 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

253 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

254 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

255 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

256 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

257 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

98 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-3: IREP INPUT – [REDACTED] BCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.070 0.021

4 [redacted] acute electrons E>15keV normal 0.265 0.080

5 [redacted] acute electrons E>15keV normal 0.269 0.081

6 [redacted] acute electrons E>15keV normal 0.033 0.010

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.027 0.0081

50 [redacted] acute photons E=30-250keV normal 0.027 0.0081

51 [redacted] acute photons E=30-250keV normal 0.027 0.0081

52 [redacted] acute photons E=30-250keV Normal 0.027 0.0081

53 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

99 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-3: IREP Input – [Redacted] BCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha Lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha Lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha Lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha Lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha Lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha Lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha Lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha Lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha Lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha Lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha Lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha Lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha Lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha Lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha Lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha Lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha Lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

98 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha Lognormal 1.77E-03 3.00E+00

101 [redacted] chronic alpha Lognormal 1.77E-03 3.00E+00

102 [redacted] chronic alpha Lognormal 5.50E-04 3.00E+00

103 [redacted] chronic alpha Lognormal 7.88E-06 3.000

104 [redacted] chronic alpha Lognormal 1.96E-04 3.000

105 [redacted] chronic alpha Lognormal 4.65E-04 3.000

106 [redacted] chronic alpha Lognormal 7.08E-04 3.000

107 [redacted] chronic alpha Lognormal 9.18E-04 3.000

108 [redacted] chronic alpha Lognormal 1.11E-03 3.000

109 [redacted] chronic alpha Lognormal 1.29E-03 3.000

110 [redacted] chronic alpha Lognormal 1.45E-03 3.000

111 [redacted] chronic alpha Lognormal 1.61E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

100 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-3: IREP Input – [Redacted] BCC [Redacted] (continued)

112 [redacted] chronic alpha Lognormal 1.76E-03 3.000

113 [redacted] chronic alpha Lognormal 1.91E-03 3.000

114 [redacted] chronic alpha Lognormal 2.06E-03 3.000

115 [redacted] chronic alpha Lognormal 2.20E-03 3.000

116 [redacted] chronic alpha Lognormal 2.34E-03 3.000

117 [redacted] chronic alpha Lognormal 2.48E-03 3.000

118 [redacted] chronic alpha Lognormal 2.63E-03 3.000

119 [redacted] chronic alpha Lognormal 2.67E-03 3.000

120 [redacted] chronic alpha Lognormal 2.60E-03 3.000

121 [redacted] chronic alpha Lognormal 2.55E-03 3.000

122 [redacted] chronic alpha Lognormal 2.50E-03 3.000

123 [redacted] chronic alpha Lognormal 2.42E-03 3.000

124 [redacted] chronic alpha Lognormal 2.37E-03 3.000

125 [redacted] chronic alpha Lognormal 2.34E-03 3.000

126 [redacted] chronic alpha Lognormal 2.32E-03 3.000

127 [redacted] chronic alpha Lognormal 2.30E-03 3.000

128 [redacted] chronic alpha Lognormal 2.30E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.31E-03 3.000

131 [redacted] chronic alpha Lognormal 2.30E-03 3.000

132 [redacted] chronic alpha Lognormal 2.31E-03 3.000

133 [redacted] chronic alpha Lognormal 2.32E-03 3.000

134 [redacted] chronic alpha Lognormal 2.33E-03 3.000

135 [redacted] chronic alpha Lognormal 2.33E-03 3.000

136 [redacted] chronic alpha Lognormal 2.34E-03 3.000

137 [redacted] chronic alpha Lognormal 2.35E-03 3.000

138 [redacted] chronic alpha Lognormal 2.37E-03 3.000

139 [redacted] chronic alpha Lognormal 2.37E-03 3.000

140 [redacted] chronic alpha Lognormal 2.38E-03 3.000

141 [redacted] chronic alpha Lognormal 2.39E-03 3.000

142 [redacted] chronic alpha Lognormal 2.41E-03 3.000

143 [redacted] chronic alpha Lognormal 9.09E-04 3.000

144 [redacted] chronic alpha Lognormal 9.09E-04 3.000

145 [redacted] chronic alpha Lognormal 9.09E-04 3.000

146 [redacted] chronic alpha Lognormal 3.47E-06 3.000

147 [redacted] chronic alpha Lognormal 6.82E-05 3.000

148 [redacted] chronic alpha Lognormal 1.51E-04 3.000

149 [redacted] chronic alpha Lognormal 2.43E-04 3.000

150 [redacted] chronic alpha Lognormal 3.42E-04 3.000

151 [redacted] chronic alpha Lognormal 4.49E-04 3.000

152 [redacted] chronic alpha Lognormal 5.63E-04 3.000

153 [redacted] chronic alpha Lognormal 6.85E-04 3.000

154 [redacted] chronic alpha Lognormal 8.08E-04 3.000

155 [redacted] chronic alpha Lognormal 9.36E-04 3.000

156 [redacted] chronic alpha Lognormal 1.07E-03 3.000

157 [redacted] chronic alpha Lognormal 1.21E-03 3.000

158 [redacted] chronic alpha Lognormal 1.35E-03 3.000

159 [redacted] chronic alpha Lognormal 1.49E-03 3.000

160 [redacted] chronic alpha Lognormal 1.63E-03 3.000

161 [redacted] chronic alpha Lognormal 1.78E-03 3.000

162 [redacted] chronic alpha Lognormal 1.90E-03 3.000

163 [redacted] chronic alpha Lognormal 1.99E-03 3.000

164 [redacted] chronic alpha Lognormal 2.08E-03 3.000

165 [redacted] chronic alpha Lognormal 2.16E-03 3.000

166 [redacted] chronic alpha Lognormal 2.22E-03 3.000

167 [redacted] chronic alpha Lognormal 2.27E-03 3.000

168 [redacted] chronic alpha Lognormal 2.32E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

101 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-3: IREP Input – [Redacted] BCC [Redacted] (continued)

169 [redacted] chronic alpha Lognormal 2.37E-03 3.000

170 [redacted] chronic alpha Lognormal 2.40E-03 3.000

171 [redacted] chronic alpha Lognormal 2.43E-03 3.000

172 [redacted] chronic alpha Lognormal 2.46E-03 3.000

173 [redacted] chronic alpha Lognormal 2.50E-03 3.000

174 [redacted] chronic alpha Lognormal 2.52E-03 3.000

175 [redacted] chronic alpha Lognormal 2.55E-03 3.000

176 [redacted] chronic alpha Lognormal 2.57E-03 3.000

177 [redacted] chronic alpha Lognormal 2.60E-03 3.000

178 [redacted] chronic alpha Lognormal 2.61E-03 3.000

179 [redacted] chronic alpha Lognormal 2.63E-03 3.000

180 [redacted] chronic alpha Lognormal 2.64E-03 3.000

181 [redacted] chronic alpha Lognormal 2.67E-03 3.000

182 [redacted] chronic alpha Lognormal 2.67E-03 3.000

183 [redacted] chronic alpha Lognormal 2.69E-03 3.000

184 [redacted] chronic alpha Lognormal 2.70E-03 3.000

185 [redacted] chronic alpha Lognormal 2.72E-03 3.000

186 [redacted] chronic alpha Lognormal 1.03E-03 3.000

187 [redacted] chronic alpha Lognormal 1.03E-03 3.000

188 [redacted] chronic alpha Lognormal 1.03E-03 3.000

189 [redacted] acute photons E=30-250keV Normal 0.018 0.005

190 [redacted] acute photons E=30-250keV Normal 0.018 0.005

191 [redacted] acute photons E=30-250keV Normal 0.018 0.005

192 [redacted] acute photons E=30-250keV Normal 0.018 0.005

193 [redacted] acute photons E=30-250keV Normal 0.018 0.005

194 [redacted] acute photons E=30-250keV Normal 0.018 0.005

195 [redacted] acute photons E=30-250keV Normal 0.018 0.005

196 [redacted] acute photons E=30-250keV Normal 0.018 0.005

197 [redacted] acute photons E=30-250keV Normal 0.018 0.005

198 [redacted] acute photons E=30-250keV Normal 0.018 0.005

199 [redacted] acute photons E=30-250keV Normal 0.018 0.005

200 [redacted] acute photons E=30-250keV Normal 0.018 0.005

201 [redacted] acute photons E=30-250keV Normal 0.018 0.005

202 [redacted] acute photons E=30-250keV Normal 0.018 0.005

203 [redacted] acute photons E=30-250keV Normal 0.018 0.005

204 [redacted] acute photons E=30-250keV Normal 0.018 0.005

205 [redacted] acute photons E=30-250keV Normal 0.018 0.005

206 [redacted] acute photons E=30-250keV Normal 0.018 0.005

207 [redacted] acute photons E=30-250keV Normal 0.018 0.005

208 [redacted] acute photons E=30-250keV Normal 0.018 0.005

209 [redacted] acute photons E=30-250keV Normal 0.018 0.005

210 [redacted] acute photons E=30-250keV Normal 0.018 0.005

211 [redacted] acute photons E=30-250keV Normal 0.003 0.001

212 [redacted] acute photons E=30-250keV Normal 0.003 0.001

213 [redacted] acute photons E=30-250keV Normal 0.003 0.001

214 [redacted] acute photons E=30-250keV Normal 0.003 0.001

215 [redacted] acute photons E=30-250keV Normal 0.003 0.001

216 [redacted] acute photons E=30-250keV Normal 0.003 0.001

217 [redacted] acute photons E=30-250keV Normal 0.003 0.001

218 [redacted] acute photons E=30-250keV Normal 0.003 0.001

219 [redacted] acute photons E=30-250keV Normal 0.003 0.001

220 [redacted] acute photons E=30-250keV Normal 0.003 0.001

221 [redacted] acute photons E=30-250keV Normal 0.003 0.001

222 [redacted] acute photons E=30-250keV Normal 0.003 0.001

223 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

224 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

225 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

102 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-3: IREP Input – [Redacted] BCC [Redacted] (continued)

226 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

252 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

253 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

254 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

255 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

256 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

257 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

258 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

259 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

260 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

261 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

262 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

263 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

264 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

265 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

103 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-4: IREP INPUT – [REDACTED] SCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.060 0.018

4 [redacted] acute electrons E>15keV normal 0.227 0.068

5 [redacted] acute electrons E>15keV normal 0.230 0.069

6 [redacted] acute electrons E>15keV normal 0.028 0.008

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.27 0.081

50 [redacted] acute photons E=30-250keV normal 0.27 0.081

51 [redacted] acute photons E=30-250keV normal 0.27 0.081

52 [redacted] acute photons E=30-250keV Normal 0.27 0.081

53 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

104 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-4: IREP Input – [Redacted] SCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

98 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

101 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

102 [redacted] chronic alpha lognormal 5.50E-04 3.00E+00

103 [redacted] chronic alpha lognormal 7.88E-06 3.000

104 [redacted] chronic alpha lognormal 1.96E-04 3.000

105 [redacted] chronic alpha Lognormal 4.65E-04 3.000

106 [redacted] chronic alpha Lognormal 7.08E-04 3.000

107 [redacted] chronic alpha Lognormal 9.18E-04 3.000

108 [redacted] chronic alpha Lognormal 1.11E-03 3.000

109 [redacted] chronic alpha Lognormal 1.29E-03 3.000

110 [redacted] chronic alpha Lognormal 1.45E-03 3.000

111 [redacted] chronic alpha Lognormal 1.61E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

105 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-4: IREP Input – [Redacted] SCC [Redacted] (continued)

112 [redacted] chronic alpha Lognormal 1.76E-03 3.000

113 [redacted] chronic alpha Lognormal 1.91E-03 3.000

114 [redacted] chronic alpha Lognormal 2.06E-03 3.000

115 [redacted] chronic alpha Lognormal 2.20E-03 3.000

116 [redacted] chronic alpha Lognormal 2.34E-03 3.000

117 [redacted] chronic alpha Lognormal 2.48E-03 3.000

118 [redacted] chronic alpha Lognormal 2.63E-03 3.000

119 [redacted] chronic alpha Lognormal 2.67E-03 3.000

120 [redacted] chronic alpha Lognormal 2.60E-03 3.000

121 [redacted] chronic alpha Lognormal 2.55E-03 3.000

122 [redacted] chronic alpha Lognormal 2.50E-03 3.000

123 [redacted] chronic alpha Lognormal 2.42E-03 3.000

124 [redacted] chronic alpha Lognormal 2.37E-03 3.000

125 [redacted] chronic alpha Lognormal 2.34E-03 3.000

126 [redacted] chronic alpha Lognormal 2.32E-03 3.000

127 [redacted] chronic alpha Lognormal 2.30E-03 3.000

128 [redacted] chronic alpha Lognormal 2.30E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.31E-03 3.000

131 [redacted] chronic alpha Lognormal 2.30E-03 3.000

132 [redacted] chronic alpha Lognormal 2.31E-03 3.000

133 [redacted] chronic alpha Lognormal 2.32E-03 3.000

134 [redacted] chronic alpha Lognormal 2.33E-03 3.000

135 [redacted] chronic alpha Lognormal 2.33E-03 3.000

136 [redacted] chronic alpha Lognormal 2.34E-03 3.000

137 [redacted] chronic alpha Lognormal 2.35E-03 3.000

138 [redacted] chronic alpha Lognormal 2.37E-03 3.000

139 [redacted] chronic alpha Lognormal 2.37E-03 3.000

140 [redacted] chronic alpha Lognormal 2.38E-03 3.000

141 [redacted] chronic alpha Lognormal 2.39E-03 3.000

142 [redacted] chronic alpha Lognormal 2.41E-03 3.000

143 [redacted] chronic alpha Lognormal 9.09E-04 3.000

144 [redacted] chronic alpha Lognormal 9.09E-04 3.000

145 [redacted] chronic alpha Lognormal 9.09E-04 3.000

146 [redacted] chronic alpha Lognormal 3.47E-06 3.000

147 [redacted] chronic alpha Lognormal 6.82E-05 3.000

148 [redacted] chronic alpha Lognormal 1.51E-04 3.000

149 [redacted] chronic alpha Lognormal 2.43E-04 3.000

150 [redacted] chronic alpha Lognormal 3.42E-04 3.000

151 [redacted] chronic alpha Lognormal 4.49E-04 3.000

152 [redacted] chronic alpha Lognormal 5.63E-04 3.000

153 [redacted] chronic alpha Lognormal 6.85E-04 3.000

154 [redacted] chronic alpha Lognormal 8.08E-04 3.000

155 [redacted] chronic alpha Lognormal 9.36E-04 3.000

156 [redacted] chronic alpha Lognormal 1.07E-03 3.000

157 [redacted] chronic alpha Lognormal 1.21E-03 3.000

158 [redacted] chronic alpha Lognormal 1.35E-03 3.000

159 [redacted] chronic alpha Lognormal 1.49E-03 3.000

160 [redacted] chronic alpha Lognormal 1.63E-03 3.000

161 [redacted] chronic alpha Lognormal 1.78E-03 3.000

162 [redacted] chronic alpha Lognormal 1.90E-03 3.000

163 [redacted] chronic alpha Lognormal 1.99E-03 3.000

164 [redacted] chronic alpha Lognormal 2.08E-03 3.000

165 [redacted] chronic alpha Lognormal 2.16E-03 3.000

166 [redacted] chronic alpha Lognormal 2.22E-03 3.000

167 [redacted] chronic alpha Lognormal 2.27E-03 3.000

168 [redacted] chronic alpha Lognormal 2.32E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

106 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-4: IREP Input – [Redacted] SCC [Redacted] (continued)

169 [redacted] chronic alpha Lognormal 2.37E-03 3.000

170 [redacted] chronic alpha Lognormal 2.40E-03 3.000

171 [redacted] chronic alpha Lognormal 2.43E-03 3.000

172 [redacted] chronic alpha Lognormal 2.46E-03 3.000

173 [redacted] chronic alpha Lognormal 2.50E-03 3.000

174 [redacted] chronic alpha Lognormal 2.52E-03 3.000

175 [redacted] chronic alpha Lognormal 2.55E-03 3.000

176 [redacted] chronic alpha Lognormal 2.57E-03 3.000

177 [redacted] chronic alpha Lognormal 2.60E-03 3.000

178 [redacted] chronic alpha Lognormal 2.61E-03 3.000

179 [redacted] chronic alpha Lognormal 2.63E-03 3.000

180 [redacted] chronic alpha Lognormal 2.64E-03 3.000

181 [redacted] chronic alpha Lognormal 2.67E-03 3.000

182 [redacted] chronic alpha Lognormal 2.67E-03 3.000

183 [redacted] chronic alpha Lognormal 2.69E-03 3.000

184 [redacted] chronic alpha Lognormal 2.70E-03 3.000

185 [redacted] chronic alpha Lognormal 2.72E-03 3.000

186 [redacted] chronic alpha Lognormal 1.03E-03 3.000

187 [redacted] chronic alpha Lognormal 1.03E-03 3.000

188 [redacted] chronic alpha Lognormal 1.03E-03 3.000

189 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

190 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

191 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

192 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

193 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

194 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

195 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

196 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

197 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

198 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

199 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

200 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

201 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

202 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

203 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

204 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

205 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

206 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

207 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

208 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

209 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

210 [redacted] acute photons E=30-250keV Normal 0.181 0.0543

211 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

212 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

213 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

214 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

215 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

216 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

217 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

218 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

219 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

220 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

221 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

222 [redacted] acute photons E=30-250keV Normal 0.031 0.0093

223 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

224 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

225 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

107 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-4: IREP Input – [Redacted] SCC [Redacted] (continued)

226 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

252 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

253 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

254 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

255 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

256 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

257 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

258 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

259 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

260 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

261 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

262 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

263 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

264 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

265 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

108 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-5: IREP INPUT – [REDACTED] BCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.070 0.021

4 [redacted] acute electrons E>15keV normal 0.265 0.080

5 [redacted] acute electrons E>15keV normal 0.269 0.081

6 [redacted] acute electrons E>15keV normal 0.033 0.010

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.027 0.0081

50 [redacted] acute photons E=30-250keV normal 0.027 0.0081

51 [redacted] acute photons E=30-250keV normal 0.027 0.0081

52 [redacted] acute photons E=30-250keV Normal 0.027 0.0081

53 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

109 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-5: IREP Input – [Redacted] BCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

98 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

101 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

102 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

103 [redacted] chronic alpha lognormal 2.11E-04 3.00E+00

104 [redacted] chronic alpha lognormal 7.88E-06 3.000

105 [redacted] chronic alpha lognormal 1.96E-04 3.000

106 [redacted] chronic alpha lognormal 4.65E-04 3.000

107 [redacted] chronic alpha lognormal 7.08E-04 3.000

108 [redacted] chronic alpha lognormal 9.18E-04 3.000

109 [redacted] chronic alpha lognormal 1.11E-03 3.000

110 [redacted] chronic alpha lognormal 1.29E-03 3.000

111 [redacted] chronic alpha lognormal 1.45E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

110 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-5: IREP Input – [Redacted] BCC [Redacted] (continued)

112 [redacted] chronic alpha lognormal 1.61E-03 3.000

113 [redacted] chronic alpha Lognormal 1.76E-03 3.000

114 [redacted] chronic alpha Lognormal 1.91E-03 3.000

115 [redacted] chronic alpha Lognormal 2.06E-03 3.000

116 [redacted] chronic alpha Lognormal 2.20E-03 3.000

117 [redacted] chronic alpha Lognormal 2.34E-03 3.000

118 [redacted] chronic alpha Lognormal 2.48E-03 3.000

119 [redacted] chronic alpha Lognormal 2.63E-03 3.000

120 [redacted] chronic alpha Lognormal 2.67E-03 3.000

121 [redacted] chronic alpha Lognormal 2.60E-03 3.000

122 [redacted] chronic alpha Lognormal 2.55E-03 3.000

123 [redacted] chronic alpha Lognormal 2.50E-03 3.000

124 [redacted] chronic alpha Lognormal 2.42E-03 3.000

125 [redacted] chronic alpha Lognormal 2.37E-03 3.000

126 [redacted] chronic alpha Lognormal 2.34E-03 3.000

127 [redacted] chronic alpha Lognormal 2.32E-03 3.000

128 [redacted] chronic alpha Lognormal 2.30E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.30E-03 3.000

131 [redacted] chronic alpha Lognormal 2.31E-03 3.000

132 [redacted] chronic alpha Lognormal 2.30E-03 3.000

133 [redacted] chronic alpha Lognormal 2.31E-03 3.000

134 [redacted] chronic alpha Lognormal 2.32E-03 3.000

135 [redacted] chronic alpha Lognormal 2.33E-03 3.000

136 [redacted] chronic alpha Lognormal 2.33E-03 3.000

137 [redacted] chronic alpha Lognormal 2.34E-03 3.000

138 [redacted] chronic alpha Lognormal 2.35E-03 3.000

139 [redacted] chronic alpha Lognormal 2.37E-03 3.000

140 [redacted] chronic alpha Lognormal 2.37E-03 3.000

141 [redacted] chronic alpha Lognormal 2.38E-03 3.000

142 [redacted] chronic alpha Lognormal 2.39E-03 3.000

143 [redacted] chronic alpha Lognormal 2.41E-03 3.000

144 [redacted] chronic alpha Lognormal 9.09E-04 3.000

145 [redacted] chronic alpha Lognormal 9.09E-04 3.000

146 [redacted] chronic alpha Lognormal 9.09E-04 3.000

147 [redacted] chronic alpha Lognormal 9.09E-04 3.000

148 [redacted] chronic alpha Lognormal 3.47E-06 3.000

149 [redacted] chronic alpha Lognormal 6.82E-05 3.000

150 [redacted] chronic alpha Lognormal 1.51E-04 3.000

151 [redacted] chronic alpha Lognormal 2.43E-04 3.000

152 [redacted] chronic alpha Lognormal 3.42E-04 3.000

153 [redacted] chronic alpha Lognormal 4.49E-04 3.000

154 [redacted] chronic alpha Lognormal 5.63E-04 3.000

155 [redacted] chronic alpha Lognormal 6.85E-04 3.000

156 [redacted] chronic alpha Lognormal 8.08E-04 3.000

157 [redacted] chronic alpha Lognormal 9.36E-04 3.000

158 [redacted] chronic alpha Lognormal 1.07E-03 3.000

159 [redacted] chronic alpha Lognormal 1.21E-03 3.000

160 [redacted] chronic alpha Lognormal 1.35E-03 3.000

161 [redacted] chronic alpha Lognormal 1.49E-03 3.000

162 [redacted] chronic alpha Lognormal 1.63E-03 3.000

163 [redacted] chronic alpha Lognormal 1.78E-03 3.000

164 [redacted] chronic alpha Lognormal 1.90E-03 3.000

165 [redacted] chronic alpha Lognormal 1.99E-03 3.000

166 [redacted] chronic alpha Lognormal 2.08E-03 3.000

167 [redacted] chronic alpha Lognormal 2.16E-03 3.000

168 [redacted] chronic alpha Lognormal 2.22E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

111 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-5: IREP Input – [Redacted] BCC [Redacted] (continued)

169 [redacted] chronic alpha Lognormal 2.27E-03 3.000

170 [redacted] chronic alpha Lognormal 2.32E-03 3.000

171 [redacted] chronic alpha Lognormal 2.37E-03 3.000

172 [redacted] chronic alpha Lognormal 2.40E-03 3.000

173 [redacted] chronic alpha Lognormal 2.43E-03 3.000

174 [redacted] chronic alpha Lognormal 2.46E-03 3.000

175 [redacted] chronic alpha Lognormal 2.50E-03 3.000

176 [redacted] chronic alpha Lognormal 2.52E-03 3.000

177 [redacted] chronic alpha Lognormal 2.55E-03 3.000

178 [redacted] chronic alpha Lognormal 2.57E-03 3.000

179 [redacted] chronic alpha Lognormal 2.60E-03 3.000

180 [redacted] chronic alpha Lognormal 2.61E-03 3.000

181 [redacted] chronic alpha Lognormal 2.63E-03 3.000

182 [redacted] chronic alpha Lognormal 2.64E-03 3.000

183 [redacted] chronic alpha Lognormal 2.67E-03 3.000

184 [redacted] chronic alpha Lognormal 2.67E-03 3.000

185 [redacted] chronic alpha Lognormal 2.69E-03 3.000

186 [redacted] chronic alpha Lognormal 2.70E-03 3.000

187 [redacted] chronic alpha Lognormal 2.72E-03 3.000

188 [redacted] chronic alpha Lognormal 1.03E-03 3.000

189 [redacted] chronic alpha Lognormal 1.03E-03 3.000

190 [redacted] chronic alpha Lognormal 1.03E-03 3.000

191 [redacted] chronic alpha Lognormal 1.03E-03 3.000

192 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

193 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

194 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

195 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

196 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

197 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

198 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

199 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

200 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

201 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

202 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

203 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

204 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

205 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

206 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

207 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

208 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

209 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

210 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

211 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

212 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

213 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

214 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

215 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

216 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

217 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

218 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

219 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

220 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

221 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

222 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

223 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

224 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

225 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

112 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-5: IREP Input – [Redacted] BCC [Redacted] (continued)

226 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

252 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

253 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

254 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

255 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

256 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

257 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

258 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

259 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

260 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

261 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

262 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

263 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

264 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

265 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

266 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

267 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

268 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

269 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

113 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-6: IREP INPUT – [REDACTED] BCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.070 0.021

4 [redacted] acute electrons E>15keV normal 0.265 0.080

5 [redacted] acute electrons E>15keV normal 0.269 0.081

6 [redacted] acute electrons E>15keV normal 0.033 0.010

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

50 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

51 [redacted] acute photons E=30-250keV normal 0.0064 0.00192

52 [redacted] acute photons E=30-250keV Normal 0.0064 0.00192

53 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

114 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-6: IREP Input – [Redacted] BCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha Lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha Lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha Lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

98 [redacted] chronic alpha Lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha Lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha Lognormal 1.77E-03 3.00E+00

101 [redacted] chronic alpha Lognormal 1.77E-03 3.00E+00

102 [redacted] chronic alpha Lognormal 1.76E-03 3.00E+00

103 [redacted] chronic alpha Lognormal 2.11E-04 3.00E+00

104 [redacted] chronic alpha Lognormal 7.88E-06 3.000

105 [redacted] chronic alpha Lognormal 1.96E-04 3.000

106 [redacted] chronic alpha Lognormal 4.65E-04 3.000

107 [redacted] chronic alpha Lognormal 7.08E-04 3.000

108 [redacted] chronic alpha Lognormal 9.18E-04 3.000

109 [redacted] chronic alpha Lognormal 1.11E-03 3.000

110 [redacted] chronic alpha Lognormal 1.29E-03 3.000

111 [redacted] chronic alpha Lognormal 1.45E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

115 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-6: IREP Input – [Redacted] BCC [Redacted] (continued)

112 [redacted] chronic alpha Lognormal 1.61E-03 3.000

113 [redacted] chronic alpha Lognormal 1.76E-03 3.000

114 [redacted] chronic alpha Lognormal 1.91E-03 3.000

115 [redacted] chronic alpha Lognormal 2.06E-03 3.000

116 [redacted] chronic alpha Lognormal 2.20E-03 3.000

117 [redacted] chronic alpha Lognormal 2.34E-03 3.000

118 [redacted] chronic alpha Lognormal 2.48E-03 3.000

119 [redacted] chronic alpha Lognormal 2.63E-03 3.000

120 [redacted] chronic alpha Lognormal 2.67E-03 3.000

121 [redacted] chronic alpha Lognormal 2.60E-03 3.000

122 [redacted] chronic alpha Lognormal 2.55E-03 3.000

123 [redacted] chronic alpha Lognormal 2.50E-03 3.000

124 [redacted] chronic alpha Lognormal 2.42E-03 3.000

125 [redacted] chronic alpha Lognormal 2.37E-03 3.000

126 [redacted] chronic alpha Lognormal 2.34E-03 3.000

127 [redacted] chronic alpha Lognormal 2.32E-03 3.000

128 [redacted] chronic alpha Lognormal 2.30E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.30E-03 3.000

131 [redacted] chronic alpha Lognormal 2.31E-03 3.000

132 [redacted] chronic alpha Lognormal 2.30E-03 3.000

133 [redacted] chronic alpha Lognormal 2.31E-03 3.000

134 [redacted] chronic alpha Lognormal 2.32E-03 3.000

135 [redacted] chronic alpha Lognormal 2.33E-03 3.000

136 [redacted] chronic alpha Lognormal 2.33E-03 3.000

137 [redacted] chronic alpha Lognormal 2.34E-03 3.000

138 [redacted] chronic alpha Lognormal 2.35E-03 3.000

139 [redacted] chronic alpha Lognormal 2.37E-03 3.000

140 [redacted] chronic alpha Lognormal 2.37E-03 3.000

141 [redacted] chronic alpha Lognormal 2.38E-03 3.000

142 [redacted] chronic alpha Lognormal 2.39E-03 3.000

143 [redacted] chronic alpha Lognormal 2.41E-03 3.000

144 [redacted] chronic alpha Lognormal 9.09E-04 3.000

145 [redacted] chronic alpha Lognormal 9.09E-04 3.000

146 [redacted] chronic alpha Lognormal 9.09E-04 3.000

147 [redacted] chronic alpha Lognormal 9.09E-04 3.000

148 [redacted] chronic alpha Lognormal 3.47E-06 3.000

149 [redacted] chronic alpha Lognormal 6.82E-05 3.000

150 [redacted] chronic alpha Lognormal 1.51E-04 3.000

151 [redacted] chronic alpha Lognormal 2.43E-04 3.000

152 [redacted] chronic alpha Lognormal 3.42E-04 3.000

153 [redacted] chronic alpha Lognormal 4.49E-04 3.000

154 [redacted] chronic alpha Lognormal 5.63E-04 3.000

155 [redacted] chronic alpha Lognormal 6.85E-04 3.000

156 [redacted] chronic alpha Lognormal 8.08E-04 3.000

157 [redacted] chronic alpha Lognormal 9.36E-04 3.000

158 [redacted] chronic alpha Lognormal 1.07E-03 3.000

159 [redacted] chronic alpha Lognormal 1.21E-03 3.000

160 [redacted] chronic alpha Lognormal 1.35E-03 3.000

161 [redacted] chronic alpha Lognormal 1.49E-03 3.000

162 [redacted] chronic alpha Lognormal 1.63E-03 3.000

163 [redacted] chronic alpha Lognormal 1.78E-03 3.000

164 [redacted] chronic alpha Lognormal 1.90E-03 3.000

165 [redacted] chronic alpha Lognormal 1.99E-03 3.000

166 [redacted] chronic alpha Lognormal 2.08E-03 3.000

167 [redacted] chronic alpha Lognormal 2.16E-03 3.000

168 [redacted] chronic alpha Lognormal 2.22E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

116 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-6: IREP Input – [Redacted] BCC [Redacted] (continued)

169 [redacted] chronic alpha Lognormal 2.27E-03 3.000

170 [redacted] chronic alpha Lognormal 2.32E-03 3.000

171 [redacted] chronic alpha Lognormal 2.37E-03 3.000

172 [redacted] chronic alpha Lognormal 2.40E-03 3.000

173 [redacted] chronic alpha Lognormal 2.43E-03 3.000

174 [redacted] chronic alpha Lognormal 2.46E-03 3.000

175 [redacted] chronic alpha Lognormal 2.50E-03 3.000

176 [redacted] chronic alpha Lognormal 2.52E-03 3.000

177 [redacted] chronic alpha Lognormal 2.55E-03 3.000

178 [redacted] chronic alpha Lognormal 2.57E-03 3.000

179 [redacted] chronic alpha Lognormal 2.60E-03 3.000

180 [redacted] chronic alpha Lognormal 2.61E-03 3.000

181 [redacted] chronic alpha Lognormal 2.63E-03 3.000

182 [redacted] chronic alpha Lognormal 2.64E-03 3.000

183 [redacted] chronic alpha Lognormal 2.67E-03 3.000

184 [redacted] chronic alpha Lognormal 2.67E-03 3.000

185 [redacted] chronic alpha Lognormal 2.69E-03 3.000

186 [redacted] chronic alpha Lognormal 2.70E-03 3.000

187 [redacted] chronic alpha Lognormal 2.72E-03 3.000

188 [redacted] chronic alpha Lognormal 1.03E-03 3.000

189 [redacted] chronic alpha Lognormal 1.03E-03 3.000

190 [redacted] chronic alpha Lognormal 1.03E-03 3.000

191 [redacted] chronic alpha Lognormal 1.03E-03 3.000

192 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

193 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

194 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

195 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

196 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

197 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

198 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

199 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

200 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

201 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

202 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

203 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

204 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

205 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

206 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

207 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

208 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

209 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

210 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

211 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

212 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

213 [redacted] acute photons E=30-250keV Normal 5.98E-03 1.79E-03

214 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

215 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

216 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

217 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

218 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

219 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

220 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

221 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

222 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

223 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

224 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04

225 [redacted] acute photons E=30-250keV Normal 1.36E-03 4.08E-04
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

117 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-6: IREP Input – [Redacted] BCC [Redacted] (continued)

226 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

227 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

228 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000

229 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

252 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

253 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

254 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

255 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

256 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

257 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

258 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

259 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

260 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

261 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

262 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

263 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

264 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

265 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

266 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

267 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

268 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

269 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

118 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

APPENDIX II.A-7: IREP INPUT – [REDACTED] SCC [REDACTED]

Exposure 

#

Exposure 

Year

Exposure 

Rate Radiation Type

Dose 

Distribution 

Type

Parameter 1 Parameter 2

1 [redacted] acute photons E=30-250keV normal 0.027 0.008

2 [redacted] acute photons E=30-250keV normal 0.115 0.035

3 [redacted] acute electrons E>15keV normal 0.070 0.021

4 [redacted] acute electrons E>15keV normal 0.265 0.080

5 [redacted] acute electrons E>15keV normal 0.269 0.081

6 [redacted] acute electrons E>15keV normal 0.033 0.010

7 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

8 [redacted] acute photons E=30-250keV lognormal 0.045 1.52

9 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

10 [redacted] acute photons E=30-250keV lognormal 0.015 1.52

11 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

12 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.061 1.52

13 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.081 1.52

14 [redacted] chronic neutrons E=100keV-2MeV lognormal 0.020 1.52

15 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

16 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

17 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

18 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

19 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

20 [redacted] acute photons E=30-250keV lognormal 0.06 1.52

21 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

22 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

23 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

24 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

25 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

26 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

27 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

28 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

29 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

30 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

31 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

32 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

33 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

34 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

35 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

36 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

37 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

38 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

39 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

40 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

41 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

42 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

43 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

44 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

45 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

46 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

47 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

48 [redacted] acute photons E=30-250keV lognormal 0.02 1.52

49 [redacted] acute photons E=30-250keV normal 0.027 0.0081

50 [redacted] acute photons E=30-250keV normal 0.027 0.0081

51 [redacted] acute photons E=30-250keV normal 0.027 0.0081

52 [redacted] acute photons E=30-250keV Normal 0.027 0.0081

53 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

54 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

119 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-7: IREP Input – [Redacted] SCC [Redacted] (continued)

55 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

56 [redacted] acute electrons E>15keV Normal 6.99E-02 2.10E-02

57 [redacted] chronic alpha lognormal 1.68E-04 3.00E+00

58 [redacted] chronic alpha lognormal 6.09E-04 3.00E+00

59 [redacted] chronic alpha lognormal 1.02E-03 3.00E+00

60 [redacted] chronic alpha lognormal 1.41E-03 3.00E+00

61 [redacted] chronic alpha lognormal 1.44E-03 3.00E+00

62 [redacted] chronic alpha lognormal 1.51E-03 3.00E+00

63 [redacted] chronic alpha lognormal 1.57E-03 3.00E+00

64 [redacted] chronic alpha lognormal 1.61E-03 3.00E+00

65 [redacted] chronic alpha lognormal 1.65E-03 3.00E+00

66 [redacted] chronic alpha lognormal 1.68E-03 3.00E+00

67 [redacted] chronic alpha lognormal 1.71E-03 3.00E+00

68 [redacted] chronic alpha lognormal 1.73E-03 3.00E+00

69 [redacted] chronic alpha lognormal 1.75E-03 3.00E+00

70 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

71 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

72 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

73 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

74 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

75 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

76 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

77 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

78 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

79 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

80 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

81 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

82 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

83 [redacted] chronic alpha lognormal 1.85E-03 3.00E+00

84 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

85 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

86 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

87 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

88 [redacted] chronic alpha lognormal 1.84E-03 3.00E+00

89 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

90 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

91 [redacted] chronic alpha lognormal 1.83E-03 3.00E+00

92 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

93 [redacted] chronic alpha lognormal 1.82E-03 3.00E+00

94 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

95 [redacted] chronic alpha lognormal 1.81E-03 3.00E+00

96 [redacted] chronic alpha lognormal 1.80E-03 3.00E+00

97 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

98 [redacted] chronic alpha lognormal 1.79E-03 3.00E+00

99 [redacted] chronic alpha lognormal 1.78E-03 3.00E+00

100 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

101 [redacted] chronic alpha lognormal 1.77E-03 3.00E+00

102 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

103 [redacted] chronic alpha lognormal 1.76E-03 3.00E+00

104 [redacted] chronic alpha lognormal 3.16E-04 3.00E+00

105 [redacted] chronic alpha lognormal 7.88E-06 3.000

106 [redacted] chronic alpha lognormal 1.96E-04 3.000

107 [redacted] chronic alpha lognormal 4.65E-04 3.000

108 [redacted] chronic alpha lognormal 7.08E-04 3.000

109 [redacted] chronic alpha lognormal 9.18E-04 3.000

110 [redacted] chronic alpha lognormal 1.11E-03 3.000

111 [redacted] chronic alpha lognormal 1.29E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

120 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-7: IREP Input – [Redacted] SCC [Redacted] (continued)

112 [redacted] chronic alpha lognormal 1.45E-03 3.000

113 [redacted] chronic alpha lognormal 1.61E-03 3.000

114 [redacted] chronic alpha Lognormal 1.76E-03 3.000

115 [redacted] chronic alpha Lognormal 1.91E-03 3.000

116 [redacted] chronic alpha Lognormal 2.06E-03 3.000

117 [redacted] chronic alpha Lognormal 2.20E-03 3.000

118 [redacted] chronic alpha Lognormal 2.34E-03 3.000

119 [redacted] chronic alpha Lognormal 2.48E-03 3.000

120 [redacted] chronic alpha Lognormal 2.63E-03 3.000

121 [redacted] chronic alpha Lognormal 2.67E-03 3.000

122 [redacted] chronic alpha Lognormal 2.60E-03 3.000

123 [redacted] chronic alpha Lognormal 2.55E-03 3.000

124 [redacted] chronic alpha Lognormal 2.50E-03 3.000

125 [redacted] chronic alpha Lognormal 2.42E-03 3.000

126 [redacted] chronic alpha Lognormal 2.37E-03 3.000

127 [redacted] chronic alpha Lognormal 2.34E-03 3.000

128 [redacted] chronic alpha Lognormal 2.32E-03 3.000

129 [redacted] chronic alpha Lognormal 2.30E-03 3.000

130 [redacted] chronic alpha Lognormal 2.30E-03 3.000

131 [redacted] chronic alpha Lognormal 2.30E-03 3.000

132 [redacted] chronic alpha Lognormal 2.31E-03 3.000

133 [redacted] chronic alpha Lognormal 2.30E-03 3.000

134 [redacted] chronic alpha Lognormal 2.31E-03 3.000

135 [redacted] chronic alpha Lognormal 2.32E-03 3.000

136 [redacted] chronic alpha Lognormal 2.33E-03 3.000

137 [redacted] chronic alpha Lognormal 2.33E-03 3.000

138 [redacted] chronic alpha Lognormal 2.34E-03 3.000

139 [redacted] chronic alpha Lognormal 2.35E-03 3.000

140 [redacted] chronic alpha Lognormal 2.37E-03 3.000

141 [redacted] chronic alpha Lognormal 2.37E-03 3.000

142 [redacted] chronic alpha Lognormal 2.38E-03 3.000

143 [redacted] chronic alpha Lognormal 2.39E-03 3.000

144 [redacted] chronic alpha Lognormal 2.41E-03 3.000

145 [redacted] chronic alpha Lognormal 9.09E-04 3.000

146 [redacted] chronic alpha Lognormal 9.09E-04 3.000

147 [redacted] chronic alpha Lognormal 9.09E-04 3.000

148 [redacted] chronic alpha Lognormal 9.09E-04 3.000

149 [redacted] chronic alpha Lognormal 9.09E-04 3.000

150 [redacted] chronic alpha Lognormal 3.47E-06 3.000

151 [redacted] chronic alpha Lognormal 6.82E-05 3.000

152 [redacted] chronic alpha Lognormal 1.51E-04 3.000

153 [redacted] chronic alpha Lognormal 2.43E-04 3.000

154 [redacted] chronic alpha Lognormal 3.42E-04 3.000

155 [redacted] chronic alpha Lognormal 4.49E-04 3.000

156 [redacted] chronic alpha Lognormal 5.63E-04 3.000

157 [redacted] chronic alpha Lognormal 6.85E-04 3.000

158 [redacted] chronic alpha Lognormal 8.08E-04 3.000

159 [redacted] chronic alpha Lognormal 9.36E-04 3.000

160 [redacted] chronic alpha Lognormal 1.07E-03 3.000

161 [redacted] chronic alpha Lognormal 1.21E-03 3.000

162 [redacted] chronic alpha Lognormal 1.35E-03 3.000

163 [redacted] chronic alpha Lognormal 1.49E-03 3.000

164 [redacted] chronic alpha Lognormal 1.63E-03 3.000

165 [redacted] chronic alpha Lognormal 1.78E-03 3.000

166 [redacted] chronic alpha Lognormal 1.90E-03 3.000

167 [redacted] chronic alpha Lognormal 1.99E-03 3.000

168 [redacted] chronic alpha Lognormal 2.08E-03 3.000
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

121 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-7: IREP Input – [Redacted] SCC [Redacted] (continued)

169 [redacted] chronic alpha Lognormal 2.16E-03 3.000

170 [redacted] chronic alpha Lognormal 2.22E-03 3.000

171 [redacted] chronic alpha Lognormal 2.27E-03 3.000

172 [redacted] chronic alpha Lognormal 2.32E-03 3.000

173 [redacted] chronic alpha Lognormal 2.37E-03 3.000

174 [redacted] chronic alpha Lognormal 2.40E-03 3.000

175 [redacted] chronic alpha Lognormal 2.43E-03 3.000

176 [redacted] chronic alpha Lognormal 2.46E-03 3.000

177 [redacted] chronic alpha Lognormal 2.50E-03 3.000

178 [redacted] chronic alpha Lognormal 2.52E-03 3.000

179 [redacted] chronic alpha Lognormal 2.55E-03 3.000

180 [redacted] chronic alpha Lognormal 2.57E-03 3.000

181 [redacted] chronic alpha Lognormal 2.60E-03 3.000

182 [redacted] chronic alpha Lognormal 2.61E-03 3.000

183 [redacted] chronic alpha Lognormal 2.63E-03 3.000

184 [redacted] chronic alpha Lognormal 2.64E-03 3.000

185 [redacted] chronic alpha Lognormal 2.67E-03 3.000

186 [redacted] chronic alpha Lognormal 2.67E-03 3.000

187 [redacted] chronic alpha Lognormal 2.69E-03 3.000

188 [redacted] chronic alpha Lognormal 2.70E-03 3.000

189 [redacted] chronic alpha Lognormal 2.72E-03 3.000

190 [redacted] chronic alpha Lognormal 1.03E-03 3.000

191 [redacted] chronic alpha Lognormal 1.03E-03 3.000

192 [redacted] chronic alpha Lognormal 1.03E-03 3.000

193 [redacted] chronic alpha Lognormal 1.03E-03 3.000

194 [redacted] chronic alpha Lognormal 1.03E-03 3.000

195 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

196 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

197 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

198 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

199 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

200 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

201 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

202 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

203 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

204 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

205 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

206 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

207 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

208 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

209 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

210 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

211 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

212 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

213 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

214 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

215 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

216 [redacted] acute photons E=30-250keV Normal 0.018 0.0054

217 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

218 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

219 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

220 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

221 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

222 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

223 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

224 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

225 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093
Effective Date:

February 24, 2014

Revision No.

0 (Draft)

Document No. 

SCA-TR-BDR2014-CN[REDACTED]

Page No.

122 of 122

NOTICE: This report has been reviewed for Privacy Act information and has been cleared for distribution. 

However, this report is pre-decisional and has not been reviewed by the Advisory Board on Radiation and Worker 

Health for factual accuracy or applicability within the requirements of 42 CFR 82.

Appendix II.A-7: IREP Input – [Redacted] SCC [Redacted] (continued)

226 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

227 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

228 [redacted] acute photons E=30-250keV Normal 0.0031 0.00093

229 [redacted] chronic electrons E>15keV Lognormal 1.08E-04 3.000

230 [redacted] chronic electrons E>15keV Lognormal 1.18E-03 3.000

231 [redacted] chronic electrons E>15keV Lognormal 1.35E-03 3.000

232 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

233 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

234 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

235 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

236 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

237 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

238 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

239 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

240 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

241 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

242 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

243 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

244 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

245 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

246 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

247 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

248 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

249 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

250 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

251 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

252 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

253 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

254 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

255 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

256 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

257 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

258 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

259 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

260 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

261 [redacted] chronic electrons E>15keV Lognormal 1.36E-03 3.000

262 [redacted] chronic electrons E>15keV Lognormal 1.31E-03 3.000

263 [redacted] chronic electrons E>15keV Lognormal 2.43E-04 3.000

264 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

265 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

266 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

267 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

268 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

269 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

270 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

271 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

272 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000

273 [redacted] chronic electrons E>15keV Lognormal 9.12E-06 3.000